Document:

EX-10.8

 Exhibit 10.8 

TUSIMPLE (CAYMAN) LIMITED 

SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

This SERIES E PREFERRED SHARE PURCHASE AGREEMENT (the “Agreement”) is made on November 27, 2020, by and
among: 
  

	1)	 Tusimple (Cayman) Limited (the “Company”), an exempted limited liability company
incorporated in the Cayman Islands; 

  

	2)	 Tusimple (Hong Kong) Limited (the “HK Co”), a limited liability company incorporated in
Hong Kong; 

  

	3)	 Beijing Tusen Zhitu Technology Co., Ltd. (the “WFOE”), a wholly foreign-owned enterprise
incorporated in the People’s Republic of China (the “PRC”); 

  

	4)	 Beijing Tusen Weilai Technology Co., Ltd. (the “DomCo”), a limited liability company
incorporated in the PRC; 

  

	5)	 TuSimple, Inc. (the “US Co”), a California corporation; 

 

	6)	 Tusimple (Hong Kong) Auto Tech Limited (“HK Auto Tech”), a limited liability company
incorporated in Hong Kong; 

  

	7)	 each Person listed in Schedule 1 (each, a “Purchaser” and collectively as updated
from time to time pursuant to the paragraph below, the “Purchasers”); 

  

	8)	 the Persons listed in Schedule 2-A (the
“Founders” and each, a “Founder”); and 

  

	9)	 the Persons listed in Schedule 2-B (the “Founder
Holdcos” and each, a “Founder Holdco”). 

 Each of the Company, the HK Co, the
WFOE, the US Co, the DomCo, HK Auto Tech, the Founders, the Founder Holdcos and the Purchasers shall be referred to individually as a “Party” and collectively as the “Parties”. Capitalized terms used herein shall
have the meaning set forth in Schedule 3 attached hereto. For the avoidance of doubt, one or more Purchasers (solely with respect to the purchase and subscription of Series E Preferred Shares) may be added as a “Party” and each be
bound by the rights and obligations of a “Purchaser” set forth hereunder (the “Additional Purchaser(s)”) on or after the date hereof but prior to January 31, 2021 by delivering an executed and dated signature page to
this Agreement, and, Schedule 1 shall be updated to reflect the same. 
 RECITALS 

WHEREAS, as of the Execution Date, (i) each Founder owns beneficially and of record one hundred percent (100%)
equity interest of its respective Founder Holdco; (ii) the Founder Holdcos collectively own beneficially and of record thirty-six point three two four percent (36.324%) of the equity interest of the Company; (iii) the Company owns
beneficially and of record one hundred percent (100%) equity interest of the HK Co; (iv) the HK Co owns beneficially and of record one hundred percent (100%) equity interest of the WFOE; (v) the WFOE owns beneficially and of record one
hundred percent (100%) equity interest of the DomCo; (vi) the Company owns beneficially and of record one hundred percent (100%) equity interest of the US Co; and (vii) the Company owns beneficial and of record one hundred percent (100%)
equity interest of HK Auto Tech. 
 WHEREAS, the Company is an exempted limited liability company and
immediately prior to the Closing shall have an authorized share capital consisting of (i) 361,897,230 ordinary shares, par 

 
value US$0.0001 per share (each an “Ordinary Share”), of which 60,542,105 Ordinary Shares are issued and fully paid-up; (ii) 20,000,000
Series A preferred shares, par value US$0.0001 per share (each a “Series A Preferred Share”), all of which have been issued; (iii) 8,218,203 Series A-2 preferred shares, par value US$0.0001 per share (each a “Series
A-2 Preferred Share”), all of which have been issued; (iv) 7,080,000 Series B-1 preferred shares, par value US$0.0001 per share (each a “Series
B-1 Preferred Share”), all of which have been issued, (v) 3,000,000 Series B-2 preferred shares, par value US$0.0001 per share (each a “Series B-2 Preferred Share”), all of which have been issued, (vi) 3,465,372 Series B-3 preferred shares, par value US$0.0001 per share (each a “Series B-3 Preferred Share”), all of which have been issued, (vii) 14,993,041 Series C preferred shares, par value US$0.0001 per share (each a “Series C Preferred Share”), all of which have been
issued, and (viii) 20,345,131 Series D-1 preferred shares, par value US$0.0001 per share (each a “Series D-1 Preferred Share”), all of
which have been issued, (ix) 50,000,000 Series E preferred shares, par value US$$0.0001 per share (each a “Series E Preferred Share”), (x) 3,928,937 Series E-1 preferred shares, par value
US$$0.0001 per share (each a “Series E-1 Preferred Share”), and (xi) 7,072,086 Series E-2 preferred shares, par value US$$0.0001 per share (each a “Series
E-2 Preferred Share”, and together with the Series A Preferred Share, the Series A-2 Preferred Share, the Series B-1 Preferred Share, the Series
B-2 Preferred Share, the Series B-3 Preferred Share, the Series C Preferred Share, Series D-1 Preferred Share, Series E Preferred
Shares, Series E-1 Preferred Shares and Series E-2 Preferred Shares, the “Preferred Shares”), none of which have been issued, in each case as set forth
in the capitalization table attached as Schedule 8 hereto. 
 WHEREAS, the Purchasers wish to purchase from
the Company the Series E Preferred Shares or the Series E-1 Preferred Shares, as applicable, to be issued by the Company pursuant to the terms and subject to the conditions of this Agreement. 

AGREEMENT 
 NOW,
THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS: 
  

	1.	 PURCHASE AND SALE OF SECURITIES 

 

	1.1	 Sale and Issuance of Series E Preferred Shares or Series
E-1 Preferred Shares 

 Subject to the terms and
conditions of this Agreement, each Purchaser agrees to, severally and not jointly, purchase at the Closing (as defined below) with respect to such Purchaser, and the Company agrees to sell and issue to such Purchaser at the Closing with respect to
such Purchaser, that number of Series E Preferred Shares or Series E-1 Preferred Shares, as applicable, set forth opposite such Purchaser’s name on Schedule 1, as may be amended from time to time
on or prior to the Closing (the “Purchased Shares” with respect to such Purchaser) for the total consideration set forth opposite such Purchaser’s name on Schedule 1, as may be amended from time to time on or
prior to the Closing (the “Purchase Price” with respect to each Purchaser). For the avoidance of doubt, the Purchase Price of the Series E Preferred Shares subscribed pursuant to this Agreement shall be at a per share purchase price
no less than US$14.1401. 
  

	1.2	 Closing; Delivery 

(a) The purchase and sale of the Purchased Shares with respect to each Purchaser shall take place remotely via the
exchange of documents and signatures at such time and place as the Company and such Purchaser may mutually agree upon, which shall, unless the Company and such Purchaser agree otherwise, be no later than five (5) Business Days after the
satisfaction or waiver of each condition to the Closing set forth in Section 2 and Section 3 (other than conditions that by their nature are to be satisfied at the Closing, but subject to the
satisfaction or waiver of such conditions at the Closing with respect to such Purchaser). The completion of the purchase and sale of the Purchased Shares with respect to a Purchaser shall be referred to as the “Closing” with respect
to such Purchaser. 

  
 2 

 (b) At the Closing with respect to each Purchaser, (i) the Company
shall (x) cause its register of members to be updated to reflect such Purchaser’s ownership of the Purchased Shares with respect to such Purchaser, (y) deliver a copy of the updated register of members of the Company to such
Purchaser, certified as a true and correct copy by the Company’s registered agent, and (z) deliver to such Purchaser copies of the share certificates representing the Purchased Shares with respect such Purchaser (the originals of which
shall be delivered to such Purchaser (or its designated custodian) within ten (10) Business Days after the Closing with respect to such Purchaser); and (ii) such Purchaser (other than Sina) shall pay or cause to be paid the Purchase Price
with respect to such Purchaser in accordance with Section 1.3. 
 (c) Each of the Company and Sina
hereby agrees that the outstanding principal (the “Convertible Loan”) under the Convertible Loan Agreement dated June 8, 2020 by and between the Company and Sina (the “Convertible Loan Agreement”) shall convert
at the Closing into that number of Purchased Shares as indicated opposite Sina’s name on Schedule 1 (the “Conversion”). Sina is purchasing such Purchased Shares by converting the amount of outstanding principal which is
owed to it under the Convertible Loan Agreement. Sina acknowledges and agrees: (i) that the Purchased Shares issued to it pursuant to this Agreement upon conversion of the Convertible Loan fully satisfy the Company’s obligation under the
Convertible Loan Agreement; (ii) that all outstanding principal under the Convertible Loan Agreement shall be automatically converted into Purchased Shares as set forth on Schedule 1 without further action on the part of the Company or
Sina and the Convertible Loan Agreement shall be automatically satisfied, extinguished and cancelled in its entirety and thereafter represents only the right of Sina to receive the Purchased Shares issuable upon such conversion as set forth on
Schedule 1; (iii) that any and all accrued interest under the Convertible Loan Agreement is waived and not payable, (iv) to waive and hereby does waive Sina’s right to any notice with respect to the transactions contemplated by the
Conversion and this Agreement required in connection with the Convertible Loan Agreement or otherwise; (v) that notwithstanding anything to the contrary with respect to Sina’s Convertible Loan, Sina shall be entitled solely to the rights
set forth in the Transaction Documents with respect to the ownership of the Purchased Shares and shall have no further rights with respect to the Convertible Loan Agreement; and (vi) upon satisfaction and cancellation of Sina’s Convertible
Loan pursuant to this Agreement, the Company will be forever released from all of its obligations and liabilities with respect to the Convertible Loan and the Convertible Loan Agreement. Notwithstanding the foregoing or anything to the contrary
contained herein, the cancellation, release and extinguishment of the Convertible Loan Agreement is effective upon the Closing, whether or not the Convertible Loan Agreement are delivered to or marked canceled by the Company. 

 

	1.3	 Closing Account 

Payment of the Purchase Price by a Purchaser to the Company shall be made by remittance of immediately available US$ funds to a
bank account of the Company designated by the Company in writing at least three (3) Business Days before the Closing with respect to such Purchaser. All bank charges and related expenses for remittance and receipt of any Purchase Price shall be
for the account of the Company. 
  

	2.	 CONDITIONS TO THE OBLIGATIONS OF THE PURCHASERS AT THE CLOSING 

The obligations of each Purchaser, severally but not jointly, to purchase its Purchased Shares at the Closing are subject to
the fulfillment, on or before the Closing with respect to such Purchaser, of each of the following conditions, unless otherwise waived in writing by such Purchaser: 
  

	2.1	 Completion of Due Diligence 

With respect to any Lead Investor Consortium Member, the Lead Investor Consortium shall have been satisfied with its business,
legal and financial due diligence review on the Group Companies. 

  
 3 

	2.2	 Material Adverse Effect 

Since the Statement Date, no event, circumstance or change shall have occurred that, individually or in the aggregate with one
or more other events, circumstances or changes, have had or reasonably could be expected to have a Material Adverse Effect on the Company or any other Group Company. 
  

	2.3	 Proceedings and Documents 

All corporate and other proceedings in connection with the transactions contemplated at the Closing and all documents
incidental thereto shall be reasonably satisfactory in form and substance to such Purchaser, and such Purchaser (or its legal counsel) shall have received all such counterpart originals and certified or other copies of such documents as reasonably
requested. Each of the Warrantors shall have (i) performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by such Warrantors; and
(ii) to the extent applicable, approved the aforesaid performance and compliance by its respective directors and shareholders’ resolutions, on or before the Closing. 
  

	2.4	 Authorizations 

The Warrantors shall have obtained all authorizations, approvals, waivers or permits of any Person or any Governmental
Authority necessary for the consummation of all of the transactions contemplated by this Agreement and other Transaction Documents, including without limitation any authorizations, approvals, waivers or permits that are required in connection with
the lawful issuance of the Purchased Shares to such Purchaser, and all such authorizations, approvals, waivers and permits shall be effective as of the Closing. The Company shall have obtained enforceable waivers in respect of any preemptive,
anti-dilution or similar rights applicable to the transactions contemplated by this Agreement and other Transaction Documents, and true copies of such waivers shall have been delivered to the Purchasers. 

 

	2.5	 Representations and Warranties 

The Fundamental Warranties shall be true, complete and correct as of the Execution date and the Closing. The representations
and warranties of the Warrantors contained in Schedule 5 (other than the Fundamental Warranties) shall be true, complete and correct in all material respects as of the Execution Date and the Closing, except for those representations and
warranties (i) that already contain any materiality qualification, which representations and warranties, to the extent already so qualified, shall instead be true, complete and correct in all respects as so qualified as of such respective dates
and (ii) that address matters only as of a particular date, which representations shall have been true, complete and correct in all respects (subject to Section 2.5(i)) as of such particular date. 

 

	2.6	 Restated Articles 

The seventh amended and restated memorandum and articles of association of the Company shall have been amended as set forth
substantially in the form and substance attached hereto as Exhibit A (the “Restated Articles”), which shall have been duly adopted by all necessary actions of the shareholders of the Company. 

 

	2.7	 Transaction Documents 

The Company, the HK Co, the US Co, the WFOE, the DomCo, HK Auto Tech, the Founders, the Founder Holdcos and certain other
parties shall have executed and delivered the Shareholders’ Agreement. 

  
 4 

	2.8	 Compliance Certificates 

Such Purchaser shall have received a certificate executed and delivered by the Warrantors, substantially in the form and
substance attached hereto as Exhibit C. 
  

	2.9	 Investment Committee Approval 

The internal authority of such Purchaser shall have approved the execution and performance of this Agreement and the other
Transaction Documents and the transactions contemplated hereby and thereby. 
  

	2.10	 Management Rights Letter 

If so requested by such Purchaser prior to Closing, the Company shall have delivered to such Purchaser a management rights
letter, in the form attached hereto as Exhibit D, addressed to such Purchaser and duly executed by the Company. 
  

	2.11	 Legal Opinions 

The Company shall have delivered to such Purchaser legal opinions dated the date of the Closing and addressed to such Purchaser
issued by the legal counsel of the Cayman Islands, customary to the transactions of this kind, and in form and substance reasonably satisfactory to such Purchaser. 
  

	2.12	 Financial Statements 

The Company shall have delivered to such Purchaser unaudited consolidated Financial Statements for the nine (9) months
ending on September 30, 2020 (the “Third-Quarter Financial Statements”). 
  

	3.	 CONDITIONS TO THE OBLIGATIONS OF THE COMPANY AT CLOSING 

The obligations of the Company to sell the Purchased Shares to each Purchaser at the Closing are subject to the fulfillment of
each of the following conditions by such Purchaser, on or before the Closing with respect to such Purchaser, unless otherwise waived in writing by the Company: 
  

	3.1	 Representations and Warranties 

The representations and warranties of such Purchaser contained in Schedule 7 shall be true, complete and correct in all
material respects as of the Execution Date and the Closing. 
  

	3.2	 Performance 

Such Purchaser shall have performed and complied with all covenants, agreements, obligations and conditions contained in this
Agreement that are required to be performed or complied with by it on or before the Closing. 
  

	3.3	 Execution of Shareholders’ Agreement 

Such Purchaser shall have executed and delivered to the Company the Shareholders’ Agreement. 

 

	4.	 REPRESENTATIONS AND WARRANTIES OF THE WARRANTORS 

The Warrantors, jointly and severally, represent and warrant to each Purchaser that the statements contained in Schedule
5 attached hereto are true, correct and complete (i) on and as of the Execution Date, and (ii) on and as of the date of the Closing with respect to such Purchaser (with the 

  
 5 

 
same effect as if made on and as of such date), except to the extent fairly and specifically disclosed in the disclosure schedule attached hereto as Schedule 6 (the “Disclosure
Schedule”), which disclosures shall be deemed to be part of the representations and warranties as if made hereunder. 
  

	5.	 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS 

Each Purchaser, severally and not jointly, represents and warrants to the Company that the statements contained in Schedule
7 attached hereto are true, correct and complete with respect to such Purchaser as of the Closing with respect to such Purchaser. 
  

	6.	 UNDERTAKINGS 

The Warrantors hereby jointly and severally covenant to each Purchaser as follows: 

 

	6.1	 Ordinary Course of Business 

From the Execution Date until the earlier of the Termination Date with respect to such Purchaser or the Closing with respect to
such Purchaser, each Group Company shall, and the Founders and the Founder Holdcos shall cause each of the Group Companies to, conduct its business in the ordinary course and shall use its commercially reasonable efforts to maintain the present
character and quality of the business, including without limitation, its present operations, physical facilities, working conditions, goodwill and relationships with lessors, licensors, suppliers, customers, employees and independent contractors.

  

	6.2	 Use of Proceeds 

In accordance with the directions of the Company’s Board of Directors, as it shall be constituted in accordance with the
Shareholders’ Agreement, the Company will use the proceeds from the sale of all the Purchased Shares for (i) general working capital; and (ii) other general corporate purposes for the Group Companies. 

 

	6.3	 Notice of Certain Events 

If at any time before the Closing, any Warrantor comes to know of any material fact or event which: (i) is in any way
inconsistent with any of the representations and warranties in this Agreement; (ii) suggests that any fact warranted hereunder may not be as warranted or may be misleading; or (iii) might affect the willingness of a prudent investor to
purchase the Purchased Shares on the terms contained in the Transaction Documents or the amount of the consideration a prudent investor would be prepared to pay for the Purchased Shares, then the Warrantors shall immediately notify each of the
Purchasers in writing, describing the fact or event in reasonable detail. 
  

	6.4	 Compliance 

The Group Companies shall, and the Founders and the Founder Holdcos shall cause the Group Companies to, at all times comply
with all applicable Laws in all material respects. 
  

	6.5	 Filing of Restated Articles  

Within ten (10) days following the Closing, the Company shall, and the Founders and Founder Holdcos shall procure the
Company to, duly file the Restated Articles with the Registrar of Companies of the Cayman Islands. 

  
 6 

	6.6	 No More Favorable Rights 

Without the prior written consent of the Lead Investor Consortium, none of the Warrantors or their respective Affiliates shall
grant or make available to any holders of, or any persons who have agreed to subscribe for, Series E Preferred Shares, Series E-1 Preferred Shares or Series E-2
Preferred Shares, any rights, privileges, protections, waivers, exemptions, terms or conditions that are more favorable than those granted or made available to the Lead Investor Consortium Members under the Transaction Documents in any respect;
provided, however, that the Lead Investor Consortium shall not unreasonably withhold or delay its consent with respect to reasonable rights and conditions granted to persons that can bring strategic value to the Company that is, or is reasonably
expected to be, material to the business of the Group Companies taken as a whole. Without prejudice to the foregoing, if any of the Warrantors or its Affiliates grants or makes available to, whether prior to, on or after the date hereof,
(i) any other holders of, or any other persons who have agreed to subscribed for, Series E Preferred Shares, Series E-1 Preferred Shares or Series E-2 Preferred
Shares, any rights, privileges, protections, waivers, exemptions, consents, terms or conditions more favorable than those granted or made available to the Lead Investor Consortium Members under the Transaction Documents (except for board seats,
observer seats, or those granted pursuant to instruments signed prior to the date hereof and fully disclosed to the Purchasers), then each Purchaser of Series E Preferred Shares shall be automatically entitled to such more favorable rights,
privileges, protections, waivers, exemptions, consents, terms or conditions, as applicable, and shall have the right to require the Warrantors to amend and restate the applicable Transaction Documents to reflect such more favorable rights,
privileges, protections, waivers, exemptions, consents, terms or conditions, as applicable, such that the undertakings set forth in the first sentence of this paragraph will remain (or become, as applicable) true and correct. 

 

	7.	 CURE OF BREACHES; INDEMNITY  

7.1 In the event of: (a) any breach or violation of, or inaccuracy or misrepresentation in, any representation or warranty made by
the Warrantors contained herein or any of the other Transaction Documents; or (b) any breach or violation of any covenant or agreement contained herein or any of the other Transaction Documents (each of (a) or (b), a
“Breach”), the Group Companies shall, jointly and severally, cure such Breach (to the extent that such Breach is curable) to the satisfaction of a Purchaser (it being understood that any cure shall be without resorting to cash or
assets of any of the Group Companies). Notwithstanding the foregoing, the Group Companies shall also, jointly and severally, indemnify such Purchaser and its Affiliates, limited partners, members, stockholders, directors, officers, employees,
agents, representatives and assigns (each, an “Indemnitee”) for any and all losses, liabilities, damages, diminution in value, liens, claims, obligations, penalties, settlements, deficiencies, costs and expenses, including without
limitation reasonable advisor’s fees and other reasonable expenses of investigation, defense and resolution of any Breach paid, suffered, sustained or incurred by the Indemnitees (each, an “Indemnifiable Loss”), resulting from,
or arising out of, or due to, directly or indirectly, any Breach; provided, however, that “diminution in value” as used in the preceding sentence shall not include any diminution in value not directly or indirectly caused by one or more
Breaches. 
 7.2 Notwithstanding the foregoing, the Group Companies shall, jointly and severally, indemnify and keep indemnified the
Indemnitees at all times and hold them harmless against any and all Indemnifiable Losses resulting from, or arising out of, or due to, directly or indirectly, any claim for (i) any material liability caused by the infringement or violation of
any intellectual property rights of any third party by any Group Company, (ii) any breach or non-performance of any of the Specified Investment Agreements, or (iii) tax which has been assessed or may
hereafter be assessed against any Group Company wholly or partly in respect of or in consequence of any event occurring or any income, profits or gains earned, accrued or received by any Group Company on or before the Closing and any costs, fees,
penalty, surcharge, fine, expenses or other liabilities incurred in connection with the investigation, assessment or the contesting of any claim, the settlement of any claim for tax, any legal proceedings in relation to any such tax, and the
enforcement of any arbitration award or judgment in relation to such tax (whether or not such tax is chargeable against or attributable to any other person), provided, however, that the Group Companies shall be under no liability in
respect of taxation: 
 (a) that is promptly cured without resorting to cash or other assets of any Group Company; 

  
 7 

 (b) to the extent that provision, reserve or allowance has been made for
such tax in the audited consolidated financial statement of the Company; 
 (c) if the liability has arisen in, and relates
to, the ordinary course of business of the Group Companies since the Statement Date; 
 (d) to the extent that the liability
arises as a result only of a provision or reserve in respect of the liability made in the Delivered Financial Statements being insufficient by reason of any increase in rates of tax announced after the Closing with retrospective effect; and 

(e) to the extent that the liability arises as a result of legislation which comes into force after the Closing and which is
retrospective in effect. 
 The survival period for any indemnity obligation relating to (x) claims for tax matters
arising under this Section 7.2 shall be the applicable statute of limitations for tax claims and (y) claims pursuant to Section 7.2(ii) shall be five years after the Closing. 

7.3 In the event that an Indemnitee suffers an Indemnifiable Loss as provided in Section 7.1 or 7.2 and
the Group Companies fail to fulfill their obligations under Section 7.1 or 7.2 to indemnify the Indemnitee for the full amount of such Indemnifiable Loss within sixty (60) days upon receipt of written notice
thereof from such Indemnitee, then the Founders and Founder Holdcos shall jointly and severally indemnify the Indemnitee any shortfall of such indemnification, provided, however, that absent fraud, willful misconduct or gross negligence
conducted by the Founders, none of the Founders’ or Founder Holdcos’ assets, other than the Ordinary Shares of the Company held by the Founders and/or Founder Holdcos, shall in any respect be used to satisfy any of the Founders and/or
Founder Holdcos’ indemnity obligations pursuant to this Agreement (and the Indemnitee shall have no right to claim against any of the Founders’ assets but for the Ordinary Shares of the Company held by the Founders and/or Founder Holdcos).
Any indemnification provided by the Warrantors other than the Founders and the Founder Holdcos pursuant to this Section 7.3 shall not prejudice or otherwise affect the right of the Indemnitee to seek indemnification from
the Group Companies pursuant to Section 7.1 or 7.2; provided, however, that to the extent an Indemnitee is able to recover any Indemnifiable Loss from the Group Companies, the Warrantors other than the
Group Companies shall not be obligated to indemnify such Indemnitee of such recovered amount. 
 7.4 If a Purchaser or other
Indemnitee believes that it has a claim that may give rise to an obligation of any Warrantor pursuant to this Section 7, it shall give prompt notice thereof to the Company stating specifically the basis on which such claim
is being made, the material facts related thereto, and the amount of the claim (or a reasonably estimate thereof) asserted. In the event of a third party claim against an Indemnitee for which such Indemnitee seeks indemnification from any Warrantor
pursuant to this Section 7, no settlement shall be deemed conclusive with respect to whether there was an Indemnifiable Loss or the amount of such Indemnifiable Loss unless such settlement is consented to by the Founders or
their Founder Holdcos. Any dispute related to this Section 7 shall be resolved pursuant to Section 8.15. 

7.5 Notwithstanding any other provisions contained herein, the Purchasers acknowledge that the indemnities under this
Section 7 shall, absent fraud, willful misconduct or gross negligence by the Warrantors, be subject to the following provisions: 

(a) the aggregate indemnification amount claimed by a Purchaser or its Indemnitees against all the Warrantors arising under or
in connection with this Agreement shall not exceed in the aggregate the amount equal to the Purchase Price paid by such Purchaser under this Agreement; 

(b) the aggregate indemnification amount claimed against all the Warrantors arising under or in connection with
Section 7.2(ii) shall not exceed US$10,000,000; and 

  
 8 

 (c) the Warrantors shall not be required to indemnify any Indemnitee for
(i) any claim unless the Indemnifiable Losses in connection with any claim or claims suffered by all the Indemnitees are US$100,000 or more, on a cumulative basis, in which case the Warrantors shall be liable for the Indemnifiable Losses in
respect to the claim from the first US$, or (ii) any claim arising out of any breach of any representation or warranty made by the Warrantors contained herein or any of the other Transaction Documents to the extent that the relevant matters
have been fairly and specifically disclosed in the Disclosure Schedule (without prejudice to the indemnification obligations arising from Section 7.2).  

 

	8.	 MISCELLANEOUS 

 

	8.1	 Survival of Warranties 

The Fundamental Warranties shall survive the Closing until the latest date permitted by Law or indefinitely if such date is not
provided. The representations and warranties of the Warrantors contained in or made pursuant to this Agreement (other than the Fundamental Warranties) shall survive the Closing for a period until two (2) years after the Closing. Any fact or
matter which is fairly and specifically disclosed in the Disclosure Schedule shall constitute notice to the Purchasers of the fact or matter so disclosed or actually known, as applicable, and the Purchasers shall be deemed to have waived any claim
against the Warrantors on account of any inconsistency between such fact or matter and any of the representations and warranties of the Warrantors in this Agreement (except where any of such fact or matter in the Disclosure Schedule is untrue,
incorrect or incomplete). 
  

	8.2	 Confidentiality 

(a) Disclosure of Terms. The terms and conditions of this Agreement, any term sheet or memorandum of understanding
entered into pursuant to the transactions contemplated hereby, all exhibits and schedules attached hereto and thereto, and the transactions contemplated hereby and thereby (collectively, the “Transaction Terms”), including their
existence, shall be considered confidential information and shall not be disclosed by any Party hereto to any third party except as permitted in accordance with the provisions set forth below. 

(b) Permitted Disclosures. Notwithstanding the foregoing, the Company may disclose (i) the existence of the
investment to its bona fide prospective purchasers, employees, bankers, lenders, accountants, legal counsels and business partners, or to any person or entity to which disclosure is approved in writing by each Purchaser, such approval not to be
unreasonably withheld; and (ii) the Transaction Terms to its current shareholders, employees, bankers, lenders, accountants and legal counsels, in each case only where such persons or entities are under appropriate nondisclosure obligations
substantially similar to those set forth in this Section 8.2, or to any person or entity to which disclosure is approved in writing by each Purchaser, which such approval is not to be unreasonably withheld. Each Purchaser
may disclose (x) the existence of the investment and the Transaction Terms to any Affiliate, legal counsels, advisors, partner, limited partner, former partner, potential partner or potential limited partner of such Purchaser and its Affiliates
and (y) the fact of its own investment to the public, in each case as it deems appropriate at its sole discretion. Any Party hereto may also provide disclosure in order to comply with applicable Laws, as set forth in
Section 8.2(c) below. 
 (c) Legally Compelled Disclosure. In the event that any Party is
requested or becomes legally compelled (including without limitation, pursuant to any applicable tax, securities, or other Laws and regulations of any jurisdiction) to disclose the existence of this Agreement or content of any of the Transaction
Terms, such Party (the “Disclosing Party”) shall provide the other Parties with prompt written notice of that fact and shall consult with the other Parties regarding such disclosure. At the request of another Party, the Disclosing
Party shall, to the extent reasonably possible and with the cooperation and reasonable efforts of the other Parties, seek a protective order, confidential treatment or other appropriate remedy. In any event, the Disclosing Party shall furnish only
that portion of the 

  
 9 

 
information that is legally required and shall exercise reasonable efforts to obtain reliable assurance that confidential treatment will be accorded to such information. 

(d) Other Exceptions. Notwithstanding any other provision of this Section 8.2, the
confidentiality obligations of the Parties shall not apply to: (i) information which a restricted Party learns from a third party having the right to make the disclosure, provided the restricted Party complies with any restrictions imposed by
the third party; (ii) information which is rightfully in the restricted Party’s possession prior to the time of disclosure by the protected Party and not acquired by the restricted Party under a confidentiality obligation; or
(iii) information which enters the public domain without breach of confidentiality by the restricted Party. 
 (e)
Press Releases, Etc. No announcements regarding a Purchaser’s investment in the Company may be made by any Party hereto in any press conference, professional or trade publication, marketing materials or otherwise to the public without
the prior written consent of such Purchaser and the Company, provided that such consent shall not be unreasonably withheld. 

(f) Other Information. The provisions of this Section 8.2 shall terminate and supersede the
provisions of any separate nondisclosure agreement executed by any of the Parties with respect to the transactions contemplated hereby. 
  

	8.3	 Transfer; Successors and Assigns 

The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and
assigns of the Parties. Save as expressly provided in this Agreement, nothing in this Agreement, express or implied, is intended to confer upon any party other than the Parties hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement. No Warrantor may assign its rights or delegate its obligations under this Agreement without the written consent of the Purchaser subscribing for at least a majority of the total
Purchased Shares. A Purchaser may assign any of its rights and obligations under this Agreement to any of its Affiliates. Any attempted assignment in violation of this Section 8.3 shall be void. 

 

	8.4	 Governing Law 

This Agreement shall be governed by and construed in accordance with the Laws of Hong Kong as to matters within the scope
thereof, without regard to its principles of conflicts of laws.  
  

	8.5	 Counterparts; Facsimile and Emails 

This Agreement may be executed and delivered by facsimile, email or other electronic signature and in two or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  

	8.6	 Titles and Subtitles 

The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or
interpreting this Agreement. 
  

	8.7	 Notices 

All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given: (a) upon personal delivery to the Party to be notified; (b) when sent by facsimile, upon receipt of confirmation of error-free transmission (or, if such confirmation is received outside normal business hour, on the next
Business Day), (c) when sent by electronic mail, upon such mail being sent unless the sending Party subsequently learns that such electronic mail was not successfully delivered; (d) five (5) days after having been delivered by registered or
certified mail, 

  
 10 

 
return receipt requested, postage prepaid; or (e) one (1) day after delivery by an internationally recognized overnight courier, specifying next day delivery, with written verification of
receipt. All communications shall be sent to the respective Parties at their address, e-mail address, or facsimile number as set forth on Schedule 9, or as subsequently modified by written notice given
in accordance with this Section 8.7. 
  

	8.8	 No Finder’s Fees 

Except as set forth in the Disclosure Schedule, each Party represents that it neither is nor will be obligated for any
finder’s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s or broker’s fee
arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which such Purchaser or any of its officers, employees, or representatives is responsible. The Company agrees to indemnify and
hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted
liability) for which any Warrantor or any of its officers, employees or representatives is responsible. 
  

	8.9	 Fees and Expenses 

Each Party hereto shall pay all of its own costs and expenses incurred in connection with the negotiation, execution, delivery
and performance of this Agreement and other Transaction Documents and the transactions contemplated hereby and thereby; provided, however, that the Company shall, upon the first Closing, reimburse the Lead Investor Consortium of legal fees and third
party consulting or advisory expenses incurred in connection with the transactions contemplated by the Transaction Documents of up to US$130,000 (to be allocated among the Lead Investor Consortium Members as agreed between them). 

 

	8.10	 Attorney’s Fees 

If any action at law or in equity (including arbitration) is necessary to enforce or interpret the terms of any of the
Transaction Documents, the prevailing Party shall be entitled to reasonable attorney’s fees, costs and necessary disbursements in addition to any other relief to which such Party may be entitled.  

 

	8.11	 Amendments and Waivers 

Any term of this Agreement (other than (i) Schedule 1, which may be amended from time to time on or prior to the Closing
or when an Additional Purchaser is added to this Agreement, and (ii) Schedule 9, which may be updated when an Additional Purchaser is added to this Agreement) may be amended or waived only with the written consent of the Company, the Founders
and each Lead Investor Consortium Member; provided that any amendment adversely affecting any Purchaser not in proportion to any other Purchaser, or any waiver of any provision providing benefit to each individual Purchaser, shall additionally
require the written consent of each affected Purchaser. Any amendment or waiver effected in accordance with this Section 8.11 shall be binding upon the Group Companies, the Founders, the Founder Holdcos, the Purchasers, and
each transferee of the Purchased Shares or the Conversion Shares and each future holder of all such securities. 
  

	8.12	 Severability 

The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other
provision. 

  
 11 

	8.13	 Delays or Omissions 

No delay or omission to exercise any right, power or remedy accruing to any Party under this Agreement, upon any breach or
default of any other Party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting Party nor shall it be construed to
be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore
or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Party of any breach or default under this Agreement, or any waiver on the part of any Party of any provisions or conditions of this
Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any Party, shall be cumulative and not alternative. 

 

	8.14	 Entire Agreement 

This Agreement (including the Schedules and Exhibits hereto) and the other Transaction Documents constitute the full and entire
understanding and agreement between the Parties with respect to the subject matter hereof and thereof, and any other written or oral agreement relating to the subject matter hereof and thereof existing between the Parties are expressly canceled.

  

	8.15	 Dispute Resolution 

Any dispute, controversy, difference or claim arising out of or relating to this Agreement, including the existence, validity,
interpretation, performance, breach or termination thereof or any dispute regarding non-contractual obligations arising out of or relating to it shall be referred to and finally resolved by arbitration
administered by the Hong Kong International Arbitration Centre (HKIAC) under the HKIAC Administered Arbitration Rules in force when the Notice of Arbitration is submitted. The seat of arbitration shall be Hong Kong. The number of arbitrators shall
be three (3). The arbitration proceedings shall be conducted in English. 
  

	8.16	 No Commitment for Additional Financing 

The Warrantors acknowledge and agree that no Purchaser has made any representation, undertaking, commitment or agreement to
provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Purchased Shares as set forth herein and subject to the conditions set forth herein. In addition, the Warrantors acknowledge and
agree that (i) no oral statements made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment,
(ii) no Warrantor shall rely on any such statement by any Purchaser or its representatives and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a
written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall
have the right, at its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing,
investment or other assistance. 
  

	8.17	 Rights Cumulative; Not Joint Liabilities 

Each and all of the various rights, powers and remedies of a Party will be considered to be cumulative with and in addition to
any other rights, powers and remedies which such Party may have at law or in equity in the event of the breach of any of the terms of this Agreement. The exercise or partial exercise of any right, power or remedy will neither constitute the
exclusive election thereof nor the waiver of any other right, power or remedy available to such Party. Notwithstanding anything to the contrary herein, the obligation and liabilities of the Purchasers hereunder and under the other Transaction
Documents shall be several and not joint. 

  
 12 

	8.18	 No Waiver 

Failure to insist upon strict compliance with any of the terms, covenants, or conditions hereof will not be deemed a waiver of
such term, covenant, or condition, nor will any waiver or relinquishment of, or failure to insist upon strict compliance with, any right, power or remedy power hereunder at any one or more times be deemed a waiver or relinquishment of such right,
power or remedy at any other time or times. 
  

	8.19	 Third Party Beneficiaries 

Each of the Indemnitees shall be a third party beneficiary of this Agreement with the full ability to enforce
Section 7 of this Agreement as if it were a Party hereto. Subject to the preceding sentence, a person who is not a party to this Agreement shall not have any rights under the Contracts (Rights of Third Parties)
Ordinance (Cap. 623 of the Laws of Hong Kong) to enforce any terms of this Agreement. The rights of the Parties to terminate, rescind or agree any variation, waiver or settlement under this Agreement are not subject to the consent of any other
person, including an Indemnitee.  
  

	8.20	 Specific Performance 

The Parties acknowledge and agree that irreparable damage would occur if any provision of this Agreement were not performed in
accordance with the terms hereof, and each Party shall be entitled to specific performance of the terms hereof. It is accordingly agreed that, each Party shall be entitled to an injunction or injunctions to prevent such breaches of this Agreement
and to enforce specifically (without proof of actual damages or harm, and not subject to any requirement for the securing or posting of any bond in connection therewith) such terms and provisions of this Agreement, this being in addition to any
other remedy to which each Party is entitled at law or in equity. 
  

	8.21	 Termination of Agreement 

 

	 	(a)	 Rights of Termination. 

This Agreement may be terminated with respect to a Purchaser before the Closing as follows: 

(1) at the election of such Purchaser on or after January 31, 2021, if the Closing with respect to such Purchaser shall
not have occurred on or before such date unless such date is extended by the mutual written consent of the Company and such Purchaser; provided that: (i) such Purchaser is not in material default of any of its obligations hereunder, and
(ii) the right to terminate this Agreement pursuant to this Section 8.21(a)(1) shall not be available to such Purchaser if its breach of any provision of this Agreement has been the cause of, or resulted in, the failure of the Closing to
be consummated by January 31, 2021. 
 (2) at the election of the Company on or after January 31, 2021, if the
Closing with respect to such Purchaser shall not have occurred on or before such date unless such date is extended by the mutual written consent of the Company and such Purchaser; provided that: (i) the Warrantors are not in material default of
any of their obligations hereunder, and (ii) the right to terminate this Agreement pursuant to this Section 8.21(a)(2) shall not be available to the Company if a Warrantor’s breach of any provision of this
Agreement has been the cause of, or resulted in, the failure of the Closing to be consummated by January 31, 2021; 

(3) by mutual written consent of the Company and such Purchaser as evidenced in writing signed by the Company and such
Purchaser; 

  
 13 

 (4) by such Purchaser in the event of any breach or violation of any
representation or warranty, covenant or agreement contained herein or in any of the other Transaction Documents by any Warrantor that is not curable or that is curable but is not cured within thirty (30) Business Days of written notice; or 

(5) by such Purchaser if any event, circumstance or change shall have occurred that, individually or in the aggregate with one
or more other events, circumstances or changes, have had or reasonably could be expected to have a Material Adverse Effect on the Company or any other Group Company. 
  

	 	(b)	 Effect of Termination. 

(1) The date of termination of this Agreement with respect to a Purchaser pursuant to Section 8.21(a)
hereof shall be referred to as “Termination Date” with respect to such Purchaser. 
 (2) In the event of
termination by the Company and/or such Purchaser pursuant to Section 8.21(a) hereof, written notice thereof shall forthwith be given to the other Parties and this Agreement shall terminate with respect to such Purchaser,
and each of the Company and such Purchaser shall be relieved of the duties and obligations among them arising under this Agreement after the date of such termination and such termination shall be without liability to the Company or such Purchaser;
provided that (i) no such termination shall relieve the Company or such Purchaser from liability for any breach of this Agreement incurred before the termination; and (ii) such termination shall not affect the rights, duties and
obligations existing between the Warrantors and any other Purchaser pursuant to this Agreement. 
 (c) Surviving
Provisions. 
 (1) The provisions of this Section 8.21, Section 7,
Section 8.1, Section 8.2, Section 8.4, Section 8.7, Section 8.9, Section 8.10,
Section 8.11, Section 8.12, Section 8.13, Section 8.15, Section 8.17, Section 8.18,
Section 8.19, and Section 8.20, hereof shall survive any termination of this Agreement. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 14 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	COMPANY:	 		 	Tusimple (Cayman) Limited
				
		 		 	 By:
	 	  /s/  Mo Chen 

		 		 	 Name: Mo Chen

		 		 	 Title: Director

			
	HK CO:	 		 	Tusimple (Hong Kong) Limited
				
		 		 	 By:
	 	  /s/  Mo Chen 

		 		 	 Name: Mo Chen

		 		 	 Title: Director

			
	HK AUTO TECH:	 		 	Tusimple (Hong Kong) Auto Tech Limited
				
		 		 	 By:
	 	  /s/  Naiyan Wang 

		 		 	 Name: Naiyan Wang

		 		 	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	WFOE:	 		 	Beijing Tusen Zhitu Technology Co., Ltd.
				
		 		 	 By:
	 	  /s/  Minhua Guo

		 		 	 Name: Minhua Guo

		 		 	 Title: Legal Representative

			
		 		 	Affix Seal: [Beijing Tusen Zhitu Technology Co., Ltd.
                    company seal is affixed]
			
	DOMCO:	 		 	Beijing Tusen Weilai Technology Co., Ltd.
				
		 		 	 By:
	 	  /s/  Minhua Guo

		 		 	 Name: Minhua Guo

		 		 	 Title: Legal Representative

			
		 		 	Affix Seal: [Beijing Tusen Weilai Technology Co., Ltd.
                    company seal is affixed]

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	US CO:	 		 	TuSimple, Inc.
				
		 		 	 By:
	 	  /s/  Xiaodi Hou

		 		 	 Name: Xiaodi Hou

		 		 	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	FOUNDERS:	 		 	Mo Chen
				
		 		 	 By:
	 	  /s/  Mo Chen

			
		 		 	Xiaodi Hou
				
		 		 	 By:
	 	  /s/  Xiaodi Hou

			
		 		 	Zhenguo Ren
				
		 		 	 By:
	 	  /s/  Zhenguo Ren

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

			
	FOUNDER HOLDCOS:	  	Gray Jade Holding Limited
		
		  	  /s/  Mo Chen

		  	 Name: Mo Chen

		  	 Title: Director

		
		  	White Marble International Limited
		
		  	  /s/  Xiaodi Hou

		  	 Name: Xiaodi Hou

		  	 Title: Director

		
		  	Ancient Jade International Limited
		
		  	  /s/  Zhenguo Ren

		  	 Name: Zhenguo Ren

		  	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Hel Ved Turbo Investment IV Inc
				
		 		 	 By:
	 	  /s/  Annie Lai

		 		 	 Name: Annie Lai

		 		 	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	LHCP Project Auto 2020 Limited
				
		 		 	 By:
	 	  /s/  Su Shan

		 		 	 Name: Su Shan

		 		 	 Title: Authorized Signatory

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Aspex Master Fund
				
		 		 	 By:
	 	  /s/  LI Ho Kei

		 		 	 Name: LI Ho Kei

		 		 	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	VectoIQ - TuSimple SPV LLC
		 		 	 By: VectoIQ – TuSimple MM LLC, its managing member

		 		 	 By: VectoIQ LLC, VectoIQ – TuSimple MM LLC’s manager

				
		 		 	 By:
	 	  /s/  Stephen Girsky

		 		 	 Name: Stephen Girsky

		 		 	 Title: Managing Member

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Fourth Avenue FF Opportunities LP – Series M
		 		 	 By its general partner, Fourth Avenue Capital

Partners GP LLC

				
		 		 	 By:
	 	  /s/  Tracy Fu

		 		 	 Name: Tracy Fu

		 		 	 Title: Managing Member

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Canadian National Railway Company
				
		 		 	 By:
	 	  /s/  Ghislain Houle

		 		 	 Name: Ghislain Houle

		 		 	 Title: Executive Vice-President & Chief Financial Officer

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Union Pacific Corporation
				
		 		 	 By:
	 	  /s/  Gary W. Grosz

		 		 	 Name: Gary W. Grosz

		 		 	 Title: Vice President and Treasurer

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Xpress Holdings, Inc.
				
		 		 	 By:
	 	  /s/  Mindy Walser

		 		 	 Name: Mindy Walser

		 		 	 Title: President

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Wanxiang International Investment, LLC
				
		 		 	 By:
	 	  /s/  Pin Ni

		 		 	 Name: Pin Ni

		 		 	 Title: Manager

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	The Goodyear Tire & Rubber Company
				
		 		 	 By:
	 	  /s/  Christopher P. Helsel

		 		 	 Name: Christopher P. Helsel

		 		 	 Title: Sr. VP & Chief Technology Officer

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Frees Properties Limited
				
		 		 	 By:
	 	  /s/  CHENG CHI MAN

		 		 	 Name: CHENG CHI MAN

		 		 	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Sunrise Drive Group Limited
				
		 		 	 By:
	 	  /s/  Thomas Chu

		 		 	 Name: Thomas Chu

		 		 	 Title: Director

  
 SIGNATURE PAGE TO SERIES
E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Sun Hung Kai Strategic Capital Limited
				
		 		 	 By:
	 	  /s/  Robert Quinlivan

		 		 	 Name: Robert Quinlivan

		 		 	 Title: Authorised signatory

				
		 		 	 By:
	 	  /s/  Elsy Li

		 		 	 Name: Elsy Li

		 		 	 Title: Authorised Signatory

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Data0.2, LLC
				
		 		 	 By:
	 	  /s/  Jason Larian

		 		 	 Name: Jason Larian

		 		 	 Title: Manager

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	JenCap Route Partners L.P.
				
		 		 	By:	 	JenCap Route GP, its general partner
				
		 		 	 By:
	 	  /s/  Tan Hainan

		 		 	 Name: Tan Hainan

		 		 	 Title: Director

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	SUN Dream Inc
				
		 		 	 By:
	 	  /s/  Charles Chao

		 		 	 Name: Charles Chao

		 		 	 Title: Director

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Navistar, Inc.
				
		 		 	 By:
	 	  /s/  Scott F. Renier

		 		 	 Name: Scott F. Renier 

		 		 	 Title: VP, Corp Development/M&A

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 SKY9 CAPITAL MVP FUND, L.P.

			
		 		 	 By: Sky9 Capital MVP GP Ltd,

		 		 	 its general partner

				
		 		 	 By:
	 	  /s/  Ronald Cao 

		 		 	 Name: Ronald Cao

		 		 	 Title: Director

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 2011 Buss Family Trust

				
		 		 	 By:
	 	  /s/  Brad Buss

		 		 	 Name: Brad Buss

		 		 	 Title: Manager

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Classic Elite Limited
				
		 		 	 By:
	 	  /s/  Peter A. Allen

		 		 	 Name: Peter A. Allen

		 		 	 Title: Director

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 Wong Ka Kit

			
		 		 	  /s/  Wong Ka Kit

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 Karen C. Francis Second Restated Revocable Trust dated

1.30.2012

				
		 		 	 By:
	 	  /s/  Karen C. Francis

		 		 	 Name: Karen C. Francis

		 		 	 Title: Trustee

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	Richard C. DeGolia Trust dated 8.27.2004
				
		 		 	By:	 	  /s/  Richard C. DeGolia

		 		 	Name: Richard C. DeGolia
		 		 	Title: Trustee

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 Werner Enterprises, Inc.

				
		 		 	 By:
	 	  /s/  Nathan Meisgeier

		 		 	 Name: Nathan Meisgeier

		 		 	 Title: Exec. Vice President & Chief Legal Officer

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 Packerland Tech Ventures LLC

				
		 		 	 By:
	 	  /s/  Thomas Jackson

		 		 	 Name: Thomas Jackson

		 		 	 Title: Vice President & Secretary

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 Socius Capital Limited

				
		 		 	 By:
	 	  /s/  Howe Leng

		 		 	 Name: Howe Leng

		 		 	 Title: Director

				
		 		 	 By:
	 	  /s/  Yu Liu

		 		 	 Name: Yu Liu

		 		 	 Title: Director

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	 PURCHASER:
	 		 	 Perry Creek Capital Partners LP

				
		 		 	 By:
	 	  /s/  Brian Zingale

		 		 	 Name: Brian Zingale

		 		 	 Title: Partner

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	Perry Creek Capital Fund II LP
				
		 		 	 By:
	 	  /s/  Brian Zingale

		 		 	 Name: Brian Zingale

		 		 	 Title: Partner

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the date first written above. 
  

							
	PURCHASER:	 		 	TuSimple.AI SPV, LLC
				
		 		 	 By:
	 	  /s/  Cheng Lu

		 		 	 Name: Cheng Lu

		 		 	 Title: Partner

 SIGNATURE PAGE TO SERIES E PREFERRED SHARE PURCHASE AGREEMENT 

 SCHEDULES AND EXHIBITS 

Schedules 
  

			
	 Schedule 1
	  	 Schedule of Purchasers

	 Schedule 2-A
	  	 Schedule of Founders

	 Schedule 2-B
	  	 Schedule of Founder Holdcos

	 Schedule 3
	  	 Definitions

	 Schedule 4
	  	 Schedule of Key Employees

	 Schedule 5
	  	 Representations and Warranties of the Warrantors

	 Schedule 6
	  	 Disclosure Schedule

	 Schedule 7
	  	 Representations and Warranties of the Purchasers

	 Schedule 8
	  	 Capitalization Table

	 Schedule 9
	  	 Notices

 SCHEDULES AND EXHIBITS 

 Exhibits 

Exhibit A        Restated Articles 

Exhibit B        Shareholders’ Agreement 

Exhibit C        Form of Compliance Certificate 

SCHEDULES AND EXHIBITS 

 SCHEDULE 1 

SCHEDULE OF PURCHASER 

  
 SCHEDULE 1 

 SCHEDULE 2-A 

SCHEDULE OF FOUNDER 

  
 SCHEDULE 2-A 

 SCHEDULE 2-B 

SCHEDULE OF FOUNDER HOLDCO 

  
 SCHEDULE 2-B 

 SCHEDULE 3 

DEFINITIONS 
  

	1.	 “Affiliate” means, with respect to any specified Person, any other Person who or which,
directly or indirectly, controls, is controlled by, or is under common control with such specified Person, including, without limitation, any general partner, limited partner, officer, director, member or employee of such Person and any venture
capital or other fund now or hereafter existing that is controlled by or under common control with one or more general partners or managing members of, or shares the same management company with, such Person. With respect to a natural person, his or
her Affiliates also include his or her children, stepchildren, grandchildren, parents, step-parents, grandparents, spouse and siblings. 

  

	2.	 “Agreement” has the meaning ascribed to it in the Preamble to this Agreement.

  

	3.	 “Anti-Corruption Laws” has the meaning set forth in Section 19 of
Schedule 5. 

  

	4.	 “Anti-Money Laundering Laws” has the meaning ascribed to it in
Section 25.4 of Schedule 5. 

  

	5.	 “Board of Directors” or “Board” means the Company’s board of
Directors. 

  

	6.	 “Breach” has the meaning ascribed to it in Section 7.1.

  

	7.	 “Business Day” means any day, other than a Saturday, Sunday or other day on which the
commercial banks in Hong Kong, Beijing, or New York are authorized or required to be closed for the conduct of regular banking business. 

  

	8.	 “Business Plan” has the meaning ascribed to it in Section 30 of
Schedule 5. 

  

	9.	 “Circular 37” means the Circular of the State Administration of Foreign Exchange on
Relevant Issues concerning Foreign Exchange Administration for Domestic Residents to Engage in Overseas Investment or Financing and in Return Investment via Special Purpose Vehicles promulgated by the State Administration of Foreign Exchange of
the PRC on July 4, 2014. 

  

	10.	 “Closing” has the meaning ascribed to it in Section 1.2(a).

  

	11.	 “Company” has the meaning ascribed to it in the Preamble. 

 

	12.	 “Company Law” means the Companies Law (as amended) of the Cayman Islands.

  

	13.	 “Confidential Information Agreements” has the meaning ascribed to it in
Section 21 of Schedule 5. 

  

	14.	 “Contract” means a legally binding contract, agreement, understanding, indenture, note,
bond, loan, instrument, lease, mortgage, franchise or license. 

  

	15.	 “Control” or “control” of a given Person means the power or authority,
whether exercised or not, to direct the business, management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, through any contractual relationship (including, without limitation, pursuant to a
management or advisory agreement) or otherwise, which power or authority shall conclusively be presumed to exist upon possession of beneficial ownership or power to direct the vote of more than fifty percent (50%) of the votes entitled to be cast at
a meeting of the members or shareholders of such Person or power to control the 

	 	 
composition of a majority of the board of directors of such Person; the terms “Controlling” and “Controlled” (and their lower-case counterparts) have meanings
correlative to the foregoing. 

  

	16.	 “Control Documents” means the Exclusive Business Cooperation and Service Agreement, Share
Pledge Agreement, Exclusive Option Agreement, and Power of Attorney in form and substance attached to any Series D-1 share purchase agreement. 

 

	17.	 “Conversion Shares” means Ordinary Shares issuable upon conversion of any Preferred Shares.

  

	18.	 “Convertible Securities” means, with respect to any specified Person, securities
convertible or exchangeable into any shares of any class of such specified Person, however described and whether voting or non-voting. 

 

	19.	 “Delivered Financial Statements” has the meaning set forth in
Section 14 of Schedule 5. 

  

	20.	 “Directors” means the members of the Board of Directors. 

 

	21.	 “Disclosing Party” has the meaning ascribed to it in
Section 8.2(c). 

  

	22.	 “Disclosure Schedule” has the meaning ascribed to it in
Section 4. 

  

	23.	 “DomCo” has the meaning ascribed to it in the preamble. 

 

	24.	 “Employee Benefit Plans” has the meaning ascribed to it in
Section 16.7 of Schedule 5. 

  

	25.	 “Equity Transfers” means (1) Hou Xiaodi (

), Hao Jianan (

), Guo Minhua (

) and Ren Zhenguo (

)’s transfers of all the equity interests they held in Shanghai Tusen Weilai Artificial Intelligence Technology Co., Ltd. (

) to the WFOE at nil consideration; and (2) Hou Xiaodi (

), Hao Jianan (

), Guo Minhua (

), Ren Zhenguo (

), and Jin Zhuo Heng Bang Technology (Beijing) Co., Ltd. (

)’s transfers of all the equity interests they held in the DomCo to the WFOE at nil consideration. 

  

	26.	 “Establishment Documents” has the meaning ascribed to it in
Section 22.4 of Schedule 5. 

  

	27.	 “Execution Date” means the date of this Agreement. 

 

	28.	 “Financial Statements” means the consolidated balance sheet, income statement and statement
of cash flows, prepared in accordance with IFRS / US GAAP and applied on a consistent basis throughout the periods indicated. 

  

	29.	 “Founder(s)” has the meaning ascribed to it in the Preamble. 

 

	30.	 “Founder Holdcos” has the meaning ascribed to it in the Preamble. 

 

	31.	 “Fundamental Warranties” means the representations and warranties by the Warrantors set
forth in Section 1, Section 2, Section 3, Section 4, Section 5, Section 6 and
Section 9 of Schedule 5. 

  

	32.	 “Governmental Authority” means the government of any nation, province, state, city,
locality or other political subdivision of any thereof, any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government, regulation or compliance, and any corporation or other entity
owned or controlled, through share or capital ownership or otherwise, by any of the foregoing. 

	33.	 “Group Companies” means the Company, the HK Co, the WFOE, the US Co, the DomCo, HK Auto
Tech, and any other direct or indirect Subsidiary of any Group Company collectively, and “Group Company” means any one of them. 

  

	34.	 “GC Product or Service” has the meaning ascribed to it in
Section 8.7 of Schedule 5. 

  

	35.	 “Half-Year Financial Statements” has the meaning set forth in
Section 14 of Schedule 5. 

  

	36.	 “Hong Kong” means the Hong Kong Special Administrative Region of the PRC.

  

	37.	 “HK Auto Tech” has the meaning ascribed to it in the Preamble. 

 

	38.	 “HK Co” has the meaning ascribed to it in the Preamble. 

 

	39.	 “IFRS” mean International Financial Reporting Standards. 

 

	40.	 “Indemnifiable Loss” has the meaning set forth in Section 7.1.

  

	41.	 “Indemnitee” has the meaning set forth in Section 7.1.

  

	42.	 “Intellectual Property” means all patents, patent applications, trademarks, service marks,
trade names, copyrights, trade secrets, processes, compositions of matter, formulas, designs, inventions, proprietary rights, know-how and any other confidential or proprietary information owned or otherwise
used by any Group Company. 

  

	43.	 “Key Employee” means each of the Persons listed in Schedule 4.

  

	44.	 “Knowledge” including the phrase “to the Warrantors’
knowledge” means the actual knowledge after reasonable investigation of the Key Employees and the Founders. 

  

	45.	 “Law” means any constitutional provision, statute or other law, rule, regulation, official
policy or interpretation of any Governmental Authority and any injunction, judgment, order, ruling, assessment or writ issued by any Governmental Authority. 

  

	46.	 “Lead Investor Consortium” means VectoIQ—TuSimple SPV LLC, Hel Ved Turbo Investment IV
Inc, LHCP Project Auto 2020 Limited and Aspex Master Fund, acting collectively, and “Lead Investor Consortium Member” means any of them. 

 

	47.	 “Lien” means any mortgage, pledge, claim, security interest, encumbrance, title defect,
lien, charge or other restriction or limitation. 

  

	48.	 “Material Adverse Effect” means a material adverse effect on the business, assets
(including intangible assets), liabilities, financial condition, property, prospects or results of operations of the Group Companies, either individually or taken as a whole. 

 

	49.	 “Material Agreements” has the meaning ascribed to it in
Section 10.1 of Schedule 5. 

  

	50.	 “OFAC” has the meaning ascribed to such term in Section 18.2(a)
of Schedule 5. 

  

	51.	 “OFAC Sanctioned Person” has the meaning ascribed to such term in
Section 18.2(b) of Schedule 5. 

	52.	 “OFAC Sanctions” has the meaning ascribed to such term in
Section 18.2(a) of Schedule 5. 

  

	53.	 “Order” or “order” means any order, injunction, judgment, decree, ruling,
writ, assessment or arbitration award of a Governmental Authority. 

  

	54.	 “Ordinary Share” has the meaning ascribed to it in the Recitals to this Agreement, being an
ordinary share of par value US$0.0001 in the capital of the Company. 

  

	55.	 “Party” and “Parties” has the meaning ascribed to it in the Preamble to
this Agreement. 

  

	56.	 “Person” means any individual, corporation, partnership, limited partnership,
proprietorship, association, limited liability company, firm, trust, estate or other enterprise or entity. 

  

	57.	 “PRC” means the Peoples’ Republic of China, excluding Hong Kong, the Macau Special
Administrative Region and Taiwan for the purpose of this Agreement. 

  

	58.	 “Projections” has the meaning ascribed to it in Section 29 of
Schedule 5. 

  

	59.	 “Preferred Share” has the meaning ascribed to it in the Recitals to this Agreement.

  

	60.	 “public official” means an employee of a Governmental Authority, a member of a political
party, a political candidate, an officer of a public international organization, or an officer or employee of a state-owned enterprise, including a PRC state-owned enterprise. 

 

	61.	 “Public Software” has the meaning ascribed to it in Section 8.7
of Schedule 5. 

  

	62.	 “Purchased Shares” has the meaning ascribed to it in Section 1.1.

  

	63.	 “Purchase Price” has the meaning ascribed to it in Section 1.1.

  

	64.	 “Purchaser” or “Purchasers” has the meaning ascribed to it in the
Preamble. 

  

	65.	 “Related Party” has the meaning ascribed to it in Section 11.4 of
Schedule 5. 

  

	66.	 “Reserve” or “reservation” has the meaning ascribed to it in
Section 4 of Schedule 5. 

  

	67.	 “Restated Articles” has the meaning ascribed to it in
Section 2.6. 

  

	68.	 “SDN List” has the meaning ascribed to such term in
Section 18.2(b) of Schedule 5. 

  

	69.	 “Secretary” has the meaning ascribed to such term in
Section 18.2(a) of Schedule 5. 

  

	70.	 “Securities Act” means the United States Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder (or comparable Laws in jurisdictions other than the United States). 

  

	71.	 “Series A Preferred Shares” has the meaning ascribed to it in the Recitals to this
Agreement. 

  

	72.	 “Series A-2 Preferred Share” has the meaning ascribed to it in the Recitals to this
Agreement. 

  

	73.	 “Series B-1 Preferred Shares” has the meaning
ascribed to it in the Recitals to this Agreement. 

	74.	 “Series B-2 Preferred Shares” has the meaning
ascribed to it in the Recitals to this Agreement. 

  

	75.	 “Series B-3 Preferred Shares” has the meaning
ascribed to it in the Recitals to this Agreement. 

  

	76.	 “Series C Preferred Shares” has the meaning ascribed to it in the Recitals to this
Agreement. 

  

	77.	 “Series D-1 Preferred Shares” has the meaning
ascribed to it in the Recitals to this Agreement. 

  

	78.	 “Series E Preferred Shares” has the meaning ascribed to it in the Recitals to this
Agreement. 

  

	79.	 “Series E-1 Preferred Shares” has the meaning
ascribed to it in the Recitals to this Agreement. 

  

	80.	 “Series E-2 Preferred Shares” has the meaning
ascribed to it in the Recitals to this Agreement. 

  

	81.	 “Seventh M&A” has the meaning ascribed to it in Section 9 of
Schedule 5. 

  

	82.	 “Shareholders’ Agreement” means the Seventh Amended and Restated Shareholders’
agreement of Tusimple (Cayman) Limited, to be entered into by and among the Group Companies, the Founders, the Purchasers and certain other parties thereto, substantially in the form and substance attached hereto as Exhibit B and as may be
amended and restated from time to time. 

  

	83.	 “Sina” means SUN Dream Inc and its successors and assignees. 

 

	84.	 “Specified Investment Agreements” means collectively, the Construction of Autonomous Truck
Research, Development and Test Center of Beijing Tusen (

) and the Supplemental Agreement with respect to the Construction of Autonomous Truck Research, Development and Test Center of Beijing Tusen (

), in each case by and between the DomCo and Sino-Japan Tangshan Caofeidian Eco-Industrial Area Administration Committee (

). 

  

	85.	 “Statement Date” has the meaning ascribed to it in Section 14 of
Schedule 5. 

  

	86.	 “Subsidiary” or “subsidiary” means, as of the relevant date of
determination, with respect to any Person (the “subject entity”), (i) any Person (x) more than 50% of whose shares or other interests entitled to vote in the election of directors or (y) more than a 50% interest in the
profits or capital of such Person are owned or controlled directly or indirectly by the subject entity or through one (1) or more Subsidiaries of the subject entity; (ii) any Person whose assets, or portions thereof, are consolidated with
the net earnings of the subject entity and are recorded on the books of the subject entity for financial reporting purposes in accordance with IFRS or US GAAP; or (iii) any Person with respect to which the subject entity has the power to
otherwise direct the business and policies of that entity directly or indirectly through another subsidiary. For the avoidance of doubt, the Subsidiaries of the Company shall include the Group Companies (other than the Company) and/or any other
company Controlled by the Company, directly or indirectly, through contractual arrangement (including via the variable interest entities arrangement). 

	87.	 “Transaction Documents” means this Agreement, the Shareholders’ Agreement (as amended
and restated from time to time), the Restated Articles (as amended and restated from time to time) and any other agreements, instruments or documents entered into in connection with this Agreement. 

 

	88.	 “Termination Date” has the meaning ascribed to it in
Section 8.21(b)(1). 

  

	89.	 “Third-Quarter Financial Statements” has the meaning set forth in
Section 2.12. 

  

	90.	 “Transaction Terms” has the meaning ascribed to it in
Section 8.2(a). 

  

	91.	 “United States Person” has the meaning ascribed to it in
Section 18.2(c) of Schedule 5. 

  

	92.	 “US Co” has the meaning ascribed to it in the Preamble. 

 

	93.	 “US GAAP” means the Generally Accepted Accounting Principles in the United States.

  

	94.	 “US$” means the United States Dollar, the lawful currency of the United States of America.

  

	95.	 “Warrantors” means the Group Companies, the Founder Holdcos and the Founders, and
“Warrantor” means any one of them. 

  

	96.	 “WFOE” has the meaning ascribed to it in the preamble. 

 SCHEDULE 4 

SCHEDULE OF KEY EMPLOYEES 

  
 SCHEDULE 4 

 SCHEDULE 5 

REPRESENTATIONS AND WARRANTIES OF THE WARRANTORS 
  

	1.	 ORGANIZATION, GOOD STANDING, CORPORATE POWER AND QUALIFICATION 

Each Warrantor (except for the Founders) is a corporation duly organized, validly existing and in good standing under the laws
of its jurisdiction of incorporation and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. Each Warrantor (except for the Founders) is duly qualified to transact business
and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect. Each Warrantor has full power, authority and capacity to enter into and perform each of the Transaction Documents to which such
Warrantor is a party. 
  

	2.	 CAPITALIZATION 

2.1 The authorized capital of the Company consists, immediately prior to the Closing, of: (a) 361,897,230 Ordinary Shares, of which
60,542,105 shares are issued and outstanding immediately prior to the Closing. All of the outstanding Ordinary Shares have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable securities laws. The
Company holds no treasury shares; and (b) 20,000,000 Series A Preferred Shares, all of which are issued and outstanding immediately prior to the Closing; 8,218,203 Series A-2 Preferred Shares, all of which are
issued and outstanding immediately prior to the Closing; 7,080,000 Series B-1 Preferred Shares, all of which are issued and outstanding immediately prior to the Closing; 3,000,000 Series B-2 Preferred Shares, all of which are issued and outstanding immediately prior to the Closing; 3,465,372 Series B-3 Preferred Shares, all of which are issued and outstanding
immediately prior to the Closing; 14,993,041 Series C Preferred Shares, all of which are issued and outstanding immediately prior to the Closing; 20,345,131 Series D-1 Preferred Shares, all of which are issued
and outstanding immediately prior to the Closing, 50,000,000 Series E Preferred Shares, none of which are issued and outstanding immediately prior to the Closing, 3,928,937 Series E-1 Preferred Shares, none of
which are issued and outstanding immediately prior to the Closing, and 7,072,086 Series E-2 Preferred Shares, none of which are issued and outstanding immediately prior to the Closing. The rights, privileges
and preferences of the Series A Preferred Shares, the Series A-2 Preferred Shares, the Series B-1 Preferred Shares, the Series B-2 Preferred Shares, the Series B-3 Preferred Shares, the Series C Preferred Shares, the Series D-1 Preferred Shares, the Series E Preferred Shares, the Series E-1
Preferred Shares and the Series E-2 Preferred Shares are as stated in the Restated Articles and as provided by the Company Law. 

2.2 The Company has reserved 21,967,694 Ordinary Shares for issuance to Key Employees, research and technical employees, officers,
directors and consultants of the Company pursuant to the 2017 Share Plan of the Company, as amended from time to time, and 4,025,680 of which are issued and outstanding. Of such reserved Ordinary Shares, 1,000,000 Ordinary Shares remain available
for issuance to Key Employees, research and technical employees, officers, directors and consultants of the Company. 
 2.3
Schedule 8 sets forth the capitalization of the Company immediately before and following the Closing including the number of shares of the following: (i) issued and outstanding Ordinary Shares, (ii) each series of Preferred Shares;
and (iii) warrants or stock purchase rights, if any. Except for (A) the conversion privileges of the Preferred Shares, (B) the right to purchase the Purchased Shares under this Agreement, (C) the rights provided in the
Shareholders’ Agreement, and (D) the warrants and stock purchase rights described in Section 2.3 of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive
rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any Ordinary Share or Preferred Share, or any securities convertible into or exchangeable for Ordinary Share or
Preferred Share. The warrants and stock purchase rights described in Section 2.3 of the Disclosure Schedule have 

  
 SCHEDULE 5 

 
been duly authorized by all necessary corporate actions of the Company and have been validly issued, without any violation of, or with duly obtained waiver of, any person’s preemptive
rights, right of first refusal or other similar rights. 
 2.4 The Founders are the legal and beneficial owners of one hundred percent
(100%) equity interest of their respective Founder Holdcos. The Founder Holdcos are the legal and beneficial owners of 56,516,425 Ordinary Shares of the Company. The Company is the sole legal and beneficial owner of one hundred percent (100%) equity
interest of the US Co. The Company is the sole legal and beneficial owner of one hundred percent (100%) equity interest of the HK Co, which in turn is the sole legal and beneficial owner of one hundred percent (100%) equity interest of the WFOE. The
WFOE is the sole legal and beneficial owner of one hundred percent (100%) equity interest of the DomCo. The Company is the sole legal and beneficial owner of one hundred percent (100%) equity interest of HK Auto Tech. 

2.5 Except as set forth in the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or,
preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire any equity interest or share capital, or any securities convertible into or exchangeable for an equity interest or share
capital, of any Group Company (other than the Company). 
  

	3.	 SUBSIDIARIES 

Section 2.4 of the Disclosure Schedule sets forth a complete structure chart of the Group Companies,
listing the full name, jurisdiction of incorporation, and shareholders (with shareholding percentage) of each Group Company (other than the Company). Other than expressly set forth in Section 2.4 of the Disclosure Schedule,
the Company and each other Group Company do not currently own or control, directly or indirectly, any interest in any other company, corporation, partnership, trust, joint venture, association, or other business entity. Neither the Company nor any
other Group Company is a participant in any joint venture, partnership or similar arrangement. 
  

	4.	 AUTHORIZATION 

With respect to each Warrantor (except for the Founders), all corporate action required to be taken by such Warrantor’s
board of directors and shareholders in order to authorize each respective Warrantor to enter into the Transaction Documents to which each such Warrantor is a party, and (only with respect to the Company) to issue the Purchased Shares at the Closing
and the Conversion Shares, has been taken or will be taken prior to the Closing. With respect to each Warrantor (except for the Founders), all action on the part of the officers of each Warrantor necessary for the execution and delivery of the
Transaction Documents, the performance of all obligations of such Warrantor under the Transaction Documents to be performed as of the Closing, and (only with respect to the Company) the issuance and delivery of the Purchased Shares has been taken or
will be taken prior to the Closing. The Transaction Documents, when executed and delivered by each Warrantor, shall constitute valid and legally binding obligations of each Warrantor, enforceable against each Warrantor in accordance with their
respective terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally,
(ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (iii) to the extent the indemnification provisions contained in the Shareholders’ Agreement may be
limited by applicable securities laws. The issuance of any Preferred Shares or Conversion Shares is not subject to any preemptive rights or rights of first refusal, or if any such preemptive rights or rights of first refusal exist, waiver of such
rights will be obtained from the holders thereof as of the Closing. For the purpose only of this Agreement, “reserve,” “reservation” or similar words with respect to a specified number of Ordinary Shares or
Preferred Shares of the Company shall mean that the Company shall, and the Board of Directors of the Company shall procure that the Company shall, refrain from issuing such number of shares so that such number of shares will remain in the authorized
but unissued share capital of the Company until the conversion rights of the holders of any Convertible Securities exercisable for such shares are exercised in accordance with the Restated Articles or otherwise. 

  
 SCHEDULE 5 

	5.	 VALID ISSUANCE OF SHARES 

5.1 The Purchased Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this
Agreement, will be validly issued, fully paid and nonassessable and free of Liens and other restrictions on transfer other than restrictions on transfer under this Agreement, the Shareholders’ Agreement, applicable securities laws and liens or
encumbrances created by or imposed by the relevant Purchaser. Subject in part to the accuracy of the representations of the Purchaser in Schedule 7 of this Agreement, the Purchased Shares will be issued in compliance with all applicable
securities laws. As of the Closing, the Conversion Shares will have been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Articles, will be validly issued, fully paid and nonassessable and free of Liens and
other restrictions on transfer other than restrictions on transfer under the Transaction Documents, applicable securities laws and liens or encumbrances created by or imposed by the relevant Purchaser. The Conversion Shares will be issued in
compliance with all applicable securities laws. 
 5.2 All presently outstanding Ordinary Shares and Preferred Shares of the Company
were duly and validly issued, fully paid and non-assessable, and are free and clear of any Liens and free of restrictions on transfer (except for any restrictions on transfer under Transaction Documents or
applicable securities laws) and have been issued in compliance in all material respects with the requirements of all applicable securities laws and regulations, including, to the extent applicable, the Securities Act. 

 

	6.	 GOVERNMENTAL CONSENTS AND FILINGS 

6.1 No consent, approval, order or authorization of or registration, qualification, designation, declaration or filing with, any
Governmental Authority on the part of any Warrantor is required in connection with the valid execution, delivery and consummation of the transactions contemplated by this Agreement, the Shareholders’ Agreement or the offer, sale, issuance or
reservation for issuance of the Purchased Shares and the Conversion Shares. 
 6.2 All products or technologies produced, designed,
tested, manufactured, fabricated, or developed by Group Companies organized in the United States are classified as EAR99 for export control purposes. 
  

	7.	 LITIGATION 

There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Warrantors’
knowledge, currently threatened (i) against any Warrantor or any officer, director or Key Employee of any Group Company that would either individually or in aggregate, reasonably be expected to have a Material Adverse Effect; or (ii) to
the Warrantors’ knowledge, that questions the validity of the Transaction Documents or the right of any Warrantor to enter into them, or to consummate the transactions contemplated by the Transaction Documents. None of the Warrantors and, to
the Warrantors’ knowledge, none of the officers, directors and Key Employees of any Group Company, is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or
instrumentality which would either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no action, suit, proceeding or investigation by any Group Company pending or which any Group Company intends to
initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Warrantors) involving the prior employment of any of the Group Company’s
employees, their services provided in connection with Group Company’s business, or any information or techniques allegedly proprietary to any of their former employers, or their obligations under any agreements with prior employers. 

  
 SCHEDULE 5 

	8.	 INTELLECTUAL PROPERTY 

8.1 Each Group Company owns or possesses sufficient legal rights to (i) all trademarks, service marks, trade names, copyrights,
trade secrets, licenses, information and proprietary rights and processes and (ii) to the Warrantors’ knowledge, all patents and patent rights, in each case of (i) and (ii), as are necessary to the conduct of such Group Company’s
business as now conducted and as presently proposed to be conducted, without any known conflict with, or infringement of, the rights of others. Section 8.1 of the Disclosure Schedule contains a complete and accurate
list of all Intellectual Property owned, licensed to or used by each Group Company, whether registered or not, and a complete and accurate list of all licenses granted by such Group Company to any third party with respect to any Intellectual
Property. No product or service marketed or sold (or proposed to be marketed or sold) by any Group Company violates or will violate any license or infringe any intellectual property rights of any other party. 

8.2 Except as set forth in the Disclosure Schedule, no Group Company has received any communications alleging that any Group Company has
violated or, by conducting its business, would violate any of the patents, trademarks, service marks, trade names, copyrights, trade secrets or other proprietary rights or processes of any other person or entity. Each Group Company has obtained and
possesses valid licenses to use all of the software programs present on the computers and other software-enabled electronic devices that it owns or leases or that it has otherwise provided to its employees for their use in connection with such Group
Company’s business. To the Warrantors’ knowledge, it will not be necessary to use any inventions of any of its employees (or persons it currently intends to hire) made prior to their employment by a Group Company. Each Key Employee has
assigned to the Group Companies all intellectual property rights he or she owns that are related to the Group Companies’ business as now conducted. Section 8.2 of the Disclosure Schedule lists all patents,
patent applications, registered trademarks, trademark applications, registered service marks, service mark applications, registered copyrights and domain names of each Group Company. 

8.3 Other than with respect to commercially available software products under standard end-user
object code license agreements, there are no outstanding options, licenses, agreements, claims, encumbrances or shared ownership interests of any kind relating to the foregoing, nor is any Group Company bound by or a party to any options, licenses
or agreements of any kind with respect to the patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, proprietary rights and processes of any other person or entity. 

8.4 No proceedings or claims in which any Group Company alleges that any person is infringing upon, or otherwise violating, its
Intellectual Property rights are pending, and none has been served, instituted or asserted by any Group Company. 
 8.5 None of the
employees of any Group Company or the Founders are obligated under any Contract (including a Contract of employment), or subject to any judgment, decree or order of any court or administrative agency, that would interfere with the use of his or her
best efforts to promote the interests of the Group Companies, or that would conflict with the business of any Group Company as presently conducted. To the Warrantors’ knowledge, it will not be necessary to utilize in the course of any Group
Company’s business operations any inventions of any of the employees of any Group Company made prior to their employment by the such Group Company, except for inventions that have been validly and properly assigned or licensed to such Group
Company as of the date hereof. 
 8.6 Each Group Company has taken all security measures that in the judgment of such Person are
commercially prudent in order to protect the secrecy, confidentiality, and value of its material Intellectual Property. 

  
 SCHEDULE 5 

 8.7 No Public Software (as defined below) forms part of any product or service
provided by any Group Company (“GC Product or Service”), and no Public Software was or is used in connection with the development of any GC Product or Service or is incorporated into, in whole or in part, or has been distributed
with, in whole or in part, any GC Product or Service. As used in this Section 8.7, “Public Software” means any software that contains, or is derived in any manner (in whole or in part) from, any software
that is distributed as free software (as defined by the Free Software Foundation), open source software (e.g., Linux or software distributed under any license approved by the Open Source Initiative as set forth www.opensource.org) or similar
licensing or distribution models which require the distribution or making available of source code as well as object code of the software to licensees without charge (except for the cost of the medium) and the right of the licensee to modify the
software and redistribute both the modified and unmodified versions of the software, including software licensed or distributed under any of the following licenses: (i) GNU’s General Public License (GPL) or Lesser/Library GPL (LGPL); (ii)
the Artistic License (e.g., PERL); (iii) the Mozilla Public License; (iv) the Netscape Public License; (v) the BSD License; or (vi) the Apache License. 
  

	9.	 COMPLIANCE WITH OTHER INSTRUMENTS 

9.1 None of the Group Companies, the Founders and the Founder Holdcos is in violation or default (i) of any provisions of its
memorandum of association (if any), articles of association or any other applicable constitutional document, (ii) of any instrument, judgment, order, writ or decree, (iii) under any note, indenture or mortgage, (iv) under any lease,
agreement, Contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Section 10.1 of Disclosure Schedule, or (v) of any provision of statute, rule or
regulation applicable to such Warrantor or any transaction documents in connection with the Company’s equity and/or debt financings prior to the Execution Date, in the case of the foregoing (ii), (iii), (iv) and (v), the violation of which
would either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There has been no material breach or violation of, or inaccuracy or misrepresentation in, any representation or warranty contained in the
Seventh Amended and Restated Memorandum of Association of the Company (“Seventh M&A”) or in the Transaction Documents (as defined in the Seventh M&A). The execution, delivery and performance of the Transaction Documents and
the consummation of the transactions contemplated by the Transaction Documents will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any
such provision, instrument, judgment, order, writ, decree, Contract or agreement or (ii) an event which results in the creation of any lien, charge or encumbrance upon any equity interest or assets of any Group Company or the suspension,
revocation, forfeiture, or nonrenewal of any material permit or license applicable to any Group Company, which would either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

9.2 PENALTIES AND FINES 

There are no penalties or fines of whatsoever nature that have ever been imposed on any Group Company. 

 

	10.	 AGREEMENTS; ACTIONS 

10.1 Save for the agreements set out in Section 10.1 of the Disclosure Schedule (the “Material
Agreements”) and the Transaction Documents, there are no other agreements, understandings, instruments, Contracts or proposed transactions to which any Group Company is a party or by which it is bound that involve (i) obligations
(contingent or otherwise) of, or payments to, any Group Company in excess of US$200,000 per annum or in excess of US$1,000,000 in the aggregate, (ii) the transfer or license of any patent, copyright, trade secret or other proprietary right to
or from any Group Company, other than from or to another Group Company or from a Founder to a Group Company, (iii) the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other person or affect any
Group Company’s exclusive right to develop, manufacture, assemble, distribute, market or sell its products, (iv) indemnification by any Group Company with respect to infringements of proprietary rights, or (v) business cooperation,
joint development, or similar arrangements involving any Group Company, and there are no agreements, understandings, instruments, Contracts or proposed 

  
 SCHEDULE 5 

 
transactions between any Warrantor and any holder of Preferred Shares amending or varying the rights or obligations of the Company and such holder of Preferred Shares from those set out in the
Transaction Documents. All the Material Agreements are valid, binding and enforceable obligations of the parties thereto and the terms thereof have been complied with by the relevant Group Company, and to the Warrantors’ knowledge, by all the
other parties thereto. There are to the Warrantors’ knowledge, no circumstances likely to give rise to any material breach of such terms, no grounds for rescission, avoidance or repudiation of any of the Material Agreements which would have a
Material Adverse Effect and no notice of termination or of intention to terminate has been received in respect of any Material Agreement. 

10.2 The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class of its
share capital, and no Group Company has (i) incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of US$100,000 or in excess of US$250,000 in the aggregate, except those in the ordinary course of
business, (ii) made any loans or advances to any person, other than ordinary advances for travel expenses and trade receivables in the ordinary course of business, or (iii) sold, exchanged or otherwise disposed of any of its assets or
rights, other than the sale of its inventory in the ordinary course of business or otherwise envisaged in this Agreement. For the purposes of Sections 10.1 and 10.2 of this Schedule 5 all indebtedness, liabilities, agreements,
understandings, instruments, Contracts and proposed transactions involving the same person or entity shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such subsection. 

10.3 No Group Company is a guarantor or indemnitor of any indebtedness of any other person, firm or corporation that is not a Group
Company. 
 10.4 Save as set out in Section 10.4 of the Disclosure Schedule or in connection with
this Agreement and the other Transaction Documents, no Group Company has engaged in the past three (3) months in any discussion with any representative of any corporation, partnership, trust, joint venture, limited liability company,
association or other entity, or any individual, regarding (i) a sale of all or substantially all of such Group Company’s assets, or (ii) any merger, consolidation or other business combination transaction of such Group Company with or
into another corporation, entity or person.  
  

	11.	 CONFLICT OF INTEREST AND RELATED PARTY TRANSACTIONS 

11.1 Other than (i) standard employee benefits generally made available to all employees, (ii) standard director and officer
indemnification agreements approved by the Board of Directors, and (iii) the purchase of the Company’s share capital in accordance with applicable law, and the issuance of options to purchase the Company’s Ordinary Shares, in each
instance, disclosed in Section 11.1 of the Disclosure Schedule, there are no agreements, understandings or proposed transactions between any Group Company and any of its officers, directors, consultants or Key
Employees, or any Affiliate thereof, respectively. 
 11.2 No Group Company is indebted, directly or indirectly, to any of its
directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee
relocation expenses. None of the Group Companies’ directors, officers or employees, or any members of their immediate families, or any Affiliate of the foregoing (i) are, directly or indirectly, indebted to any Group Company or,
(ii) to the Warrantors’ knowledge, have any direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which any Group Company has a business relationship, or any firm or corporation which
competes with any Group Company except that directors, officers or employees or shareholders of the Company may own shares in (but not exceeding one percent (1%) of the outstanding shares of) publicly traded companies that may compete with any Group
Company. To the Warrantors’ knowledge, none of the Group Companies’ employees, officers or directors or any members of their immediate families or any Affiliate of any of the foregoing are, directly or indirectly, interested in any
Contract with any Group Company. To the 

  
 SCHEDULE 5 

 
Warrantors’ knowledge, none of the Group Companies’ directors, officers or employees, or any members of their immediate families, or any Affiliate of the foregoing has any material
commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with any of the Group Companies’ five (5) largest business relationship partners, clients, service providers, joint venture partners,
licensees or competitors. 
 11.3 Other than the Group Companies, there are no corporations, partnerships, trusts, joint ventures,
limited liability companies or other business entities in which any Founder owns or controls, directly or indirectly, 10% or more of the outstanding voting interests. 

11.4 To the Warrantors’ knowledge, no employee, officer, or director of any Group Company (“Related Party”) or any
members of such Related Party’s immediate families, or any corporation, limited liability company, partnership or other entity in which such Related Party is an officer, director or partner, has significant ownership interests or otherwise
controls, loans, or extend or guarantee credit to any of the Group Companies. To the Warrantors’ knowledge, none of foregoing persons has any direct or indirect ownership interest in any firm or corporation with which any Group Company is
affiliated or with which any Group Company has a business relationship, or any firm or corporation that competes with any Group Company, except that employees, officers, or directors of the Company and members of such Related Party’s immediate
families may own stock in (but not exceeding one percent (1%) of the outstanding shares of) publicly traded companies that may compete with any Group Company. To the Warrantors’ knowledge, no Related Party or member of their immediate family is
directly or indirectly interested in any material Contract with any Group Company. 
  

	12.	 RIGHTS OF REGISTRATION AND VOTING RIGHTS 

Except as provided in the Shareholders’ Agreement, no Group Company is under any obligation to register under the
Securities Act or any other applicable securities laws, any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Warrantors’ knowledge, except as
contemplated in the Shareholders’ Agreement, no shareholder of any Group Company has entered into any agreements with respect to the voting of shares in the capital of the Company. Except as contemplated by or disclosed in the Transaction
Documents, no Founder is a party to or has any Knowledge of any agreements, written or oral, relating to the acquisition, disposition, registration under the Securities Act, or voting of the shares or securities of any Group Company. 

 

	13.	 ABSENCE OF LIENS 

Each Group Company has good and valid title to all of its respective assets, whether tangible or intangible (including
those reflected in the Delivered Financial Statements, together with all assets acquired thereby since the Statement Date (as defined below), but excluding those that have been disposed of since the Statement Date). The property and assets
owned by the Group Companies are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the
ordinary course of business and do not materially impair the Group Companies’ ownership or use of such property or assets. With respect to the property and assets it leases, each Group Company is in compliance with such leases and, to the
Warrantors’ knowledge, holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The assets owned or leased by the Group Companies constitute all of the assets used in
connection with the businesses of the Group Companies and are adequate for Group Companies to conduct such businesses in substantially the same manner as currently conducted. 
  

	14.	 FINANCIAL STATEMENTS 

The Company has delivered to the Purchaser its unaudited consolidated Financial Statements for the six months ending on
June 30, 2020 (the “Statement Date”) (the “Half-Year Financial  

  
 SCHEDULE 5 

 
Statements”), and will deliver to the Purchaser the Third Quarter Financial Statements prior to Closing (together with the Half-Year Financial Statements, the “Delivered
Financial Statements”). The Delivered Financial Statements may not contain all footnotes required by generally accepted accounting principles. Such Delivered Financial Statements fairly present in all material respects the financial
condition and operating results of the Group Companies as of the dates, and for the periods, indicated therein, subject in the case of the unaudited consolidated Financial Statements to normal year-end audit
adjustments. Except as set forth in such Delivered Financial Statements, each Group Company has no material liabilities or obligations, contingent or otherwise, as of the Statement Date and as of September 30, 2020, other than
(i) liabilities incurred in the ordinary course of business subsequent to September 30, 2020, (ii) obligations under Contracts and commitments incurred in the ordinary course of business and (iii) liabilities and obligations of a type
or nature not required under IFRS / US GAAP to be reflected in such unaudited consolidated Financial Statements. 
  

	15.	 CHANGES 

Since the Statement Date, except as set forth in Section 15 of the Disclosure Schedule or as
contemplated by this Agreement or the Transaction Documents, there has not been: 
 (a) any change in the assets,
liabilities, financial condition or operating results of any Group Company from that reflected in the Half-Year Financial Statements, except changes in the ordinary course of business; 

(b) any damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect on a Group
Company; 
 (c) any waiver or compromise by any Group Company of a valuable right or of a material debt owed to it; 

(d) any satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by any Group Company, except
in the ordinary course of business; 
 (e) any material change to a material Contract or agreement by which any Group Company
or any of its assets is bound or subject; 
 (f) any material change in any compensation arrangement or agreement with any
employee, officer, director or shareholder; 
 (g) any resignation or termination of employment or change of terms of
employment of any officer or Key Employee of any Group Company; 
 (h) any mortgage, pledge, transfer of a security interest
in, or lien, created by any Group Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair such
Company’s ownership or use of such property or assets; 
 (i) any dividend, loans or guarantees made by any Group
Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business; 

(j) any default under, acceleration of or otherwise failure to pay, any loans, notes or other indebtedness as they become due;

 (k) any declaration, setting aside or payment or other distribution in respect of any Group Company’s share capital,
or any direct or indirect redemption, purchase, or other acquisition of any of such shares by any Group Company; 

  
 SCHEDULE 5 

 (l) any sale, assignment or transfer of any material assets or Intellectual
Property of any Group Company; 
 (m) receipt of notice that there has been a loss of, or material order cancellation by, any
major customer of any Group Company; 
 (n) to the Warrantors’ knowledge, any other event or condition of any character,
other than events affecting the economy or the Company’s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or 

(o) any arrangement, agreement or commitment by the Company to do any of the things described in this
Section 15. 
  

	16.	 EMPLOYEE MATTERS 

16.1 Section 16.1 of the Disclosure Schedule sets forth a detailed description of all deferred compensation paid or
payable for each officer, employee, consultant and independent contractor of any Group Company. The compensation of Key Employees and other employees with the highest amount of compensation have been disclosed to the Purchasers. 

16.2 No employee of any Group Company is obligated under any Contract (including licenses, covenants or commitments of any nature) or
other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee’s ability to promote the interest of the Group Companies or that would conflict with the
Group Companies’ business. Neither the execution or delivery of the Transaction Documents, nor the carrying on of the Company’s business by the employees of the Group Companies, nor the conduct of the business as now conducted and as
presently proposed to be conducted, will conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any Contract, covenant or instrument under which any such employee is now obligated. 

16.3 No Group Company is delinquent in payments to any of its employees, consultants, or independent contractors for any wages,
salaries, commissions, bonuses, or other direct compensation for any service performed for it to the date hereof or amounts required to be reimbursed to such employees, consultants, or independent contractors. Each Group Company has complied in all
respects with all applicable Laws related to employment, including those related to wages, hours, worker classification, and collective bargaining, and the payment and withholding of taxes and other sums as required by Law except where noncompliance
with any applicable Law would not result in a Material Adverse Effect. Each Group Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be
withheld from employees of such Group Company and is not liable for any arrears of wages, taxes, penalties, or other sums for failure to comply with any of the foregoing. 

16.4 No Key Employee intends to terminate employment with any Group Company or is otherwise likely to become unavailable to continue as
a Key Employee, nor does any Group Company have a present intention to terminate the employment of any of the foregoing. All employees of the Group Companies have entered into an employment agreement and a confidentiality, non-competition and intellectual property rights agreement. Except as required by law, upon termination of the employment of any employee of the Group Companies, no severance or other payments will become due. The
Company has no policy, practice, plan, or program of paying severance pay or any form of severance compensation in connection with the termination of employment services. 

  
 SCHEDULE 5 

 16.5 The Company has not made any representations regarding equity incentives to any
officer, employees, director or consultant that are inconsistent with the share amounts and terms set forth in the Company’s Board minutes. 

16.6 Each former Key Employee whose employment was terminated by the Company has entered into an agreement with the Company providing
for the full release of any claims against the Company or any related party arising out of such employment. 
 16.7 Section
16.7 of the Disclosure Schedule sets forth each and every employee benefit plan maintained, established or sponsored by any Group Company, or in which any Group Company participates in or contributes to in any jurisdiction,
including without limitation, the PRC (the “Employee Benefit Plans”). Save as set out in Section 16.7 of the Disclosure Schedule, there is no other pension, retirement, social insurance,
medical insurance, profit-sharing, deferred compensation, bonus, incentive or other employee benefit program, arrangement, agreement or understanding to which any Group Company contributes, is bound, or under which any employees or former employees
(or their beneficiaries) are eligible to participate or derive a benefit. Each Group Company has made all required contributions under all the Employee Benefit Plans including without limitation all contributions required to be made under the PRC
social insurance and housing fund schemes, and has complied in all material respects with all applicable Laws of any jurisdiction, in relation to the Employee Benefit Plans. 

16.8 No Group Company is bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral,
express or implied, Contract, commitment or arrangement with any labor union, and no labor union has requested or, to the Warrantors’ knowledge, has sought to represent any of the employees, representatives or agents of any Group Company. There
is no strike or other labor dispute involving any Group Company pending, or to the Warrantors’ knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its
employees. 
 16.9 To the Warrantors’ knowledge, none of the Founders and other Key Employees or directors of any Group Company
during the previous four (4) years, has been (a) subject to voluntary or involuntary petition under any applicable bankruptcy laws or any state insolvency laws or the appointment of manager, a receiver or similar officer by a court for
his/her business or property; (b) convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (c) subject to any order, judgment, or decree (not subsequently
reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining him from engaging, or otherwise imposing limits or conditions on his engagement in any securities, investment advisory, banking, insurance,
or other type of business or acting as an officer or director of a public company; or (d) found by a court of competent jurisdiction in a civil action or by any relevant regulatory organization to have violated any applicable securities,
commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.  
  

	17.	 TAX MATTERS 

17.1 The provisions for taxes as shown on the balance sheet included in the Delivered Financial Statements are sufficient in all
material respects for the payment of all accrued and unpaid applicable taxes of the Group Companies as of the date of each such balance sheet, whether or not assessed or disputed as of the date of each such balance sheet. There have been no
examinations or audits of any taxes or tax returns or reports of any Group Company by any applicable Governmental Authority other than routine requests for information. To the Warrantors’ knowledge, there are no deficiencies or claims for any
taxes assessed, proposed or asserted in writing against any Group Company by any Governmental Authority that have not been fully paid and satisfied. Each Group Company has filed or caused to be filed on a timely basis (taking into account all
applicable extensions) all tax returns that are or were required to be filed (to the extent applicable), all such returns are correct and complete, and each 

  
 SCHEDULE 5 

 
Group Company has paid all taxes that have become due, or have reflected such taxes in accordance with IFRS (or any internationally recognized accounting standards acceptable to each Purchaser)
as a reserve for taxes on the Delivered Financial Statements. There are in effect no waivers of applicable statutes of limitations with respect to taxes for any year. No Group Company has entered into any transaction a purpose of which is the
avoidance of taxes in violation of applicable Laws. 
 17.2 Immediately after the Closing, the Company will not be a “controlled
foreign corporation” as defined in the U.S. Internal Revenue Code of 1986, as amended (or any successor thereto) (the “Code”) with respect to the stock held by the Purchasers. 

17.3 No member of the Group Company is, nor expects to become, a “passive foreign investment company” as described in
Section 1297 of the Code, as amended. 
 17.4 No shareholder of any member of a Group Company, solely by virtue of its status as
shareholder of such Group Company, has personal liability under local law for the debts and claims of such Group Company. There has been no communication from any tax authority relating to or affecting the tax classification of any member of the
Group Companies. 
  

	18.	 OFAC COMPLIANCE 

18.1 None of the Warrantors, any of their Subsidiaries, or to the Warrantor’s knowledge after due inquiry, any directors,
administrators, officers, board of directors (supervisory and management) members or employees of the Company or any other Group Company is an OFAC Sanctioned Person (as defined below). The Warrantors and, to the Warrantors’ knowledge, their
directors, administrators, officers, administrators, board of directors (supervisory and management) members or employees are in compliance with, and have not previously violated, the USA Patriot Act of 2001, and all other applicable Anti-Money
Laundering Laws. To the Warrantors’ knowledge, none of (i) the purchase and sale of the Purchased Shares, (ii) the execution, delivery and performance of this Agreement or any of the documents in Exhibits attached hereto, or
(iii) the consummation of any transaction contemplated hereby or thereby, or the fulfillment of the terms hereof or thereof, will result in a violation by any Warrantor or any Key Employee, of any of the OFAC Sanctions or of any Anti-Money
Laundering Laws. 
 18.2 For the purposes of Section 18.1: 

(a) “OFAC Sanctions” means any sanctions program administered by the Office of Foreign Assets Control of the
United States Department of the Treasury (“OFAC”) under authority delegated to the Secretary of the Treasury (the “Secretary”) by the President or provided to the Secretary by statute, and any order or license
issued by, or under authority delegated by, the President or provided to the Secretary by statute in connection with a sanctions program thus administered by OFAC. For ease of reference, and not by way of limitation, OFAC Sanctions programs are
described on OFAC’s website at www.treas.gov/ofac. 
 (b) “OFAC Sanctioned Person” means any
government, country, corporation or other entity, group or individual with whom or which the OFAC Sanctions prohibit a United States Person from engaging in transactions, and includes without limitation any individual or corporation or other entity
that appears on the current OFAC list of Specially Designated Nationals and Blocked Persons (the “SDN List”). For ease of reference, and not by way of limitation, OFAC Sanctioned Persons other than government and countries can be
found on the SDN List on OFAC’s website at
https://home.treasury.gov/policy-issues/financial-sanctions/specially-designated-nationals-and-blocked-persons-list-sdn-human-readable-lists.
 

  
 SCHEDULE 5 

 (c) “United States Person” means any United States citizen,
permanent resident alien, entity organized under the laws of the United States (including foreign branches), or any person (individual or entity) in the United States, and, with respect to the Cuban Assets Control Regulations, also includes any
corporation or other entity that is owned or controlled by one of the foregoing, without regard to where it is organized or doing business. 
  

	19.	 ANTI-CORRUPTION LAWS 

None of the Warrantors, their respective Subsidiaries, or to the Warrantor’s knowledge after due inquiry, any of their
directors, administrators, officers, board of directors (supervisory and management) members or employees have, directly or indirectly, (A) made any payment or promise to pay, or gift or promise to give or authorized such a promise or gift, of
any money or anything of value, directly or indirectly, to (a) any foreign official (as such term is defined in the U.S. Foreign Corrupt Practices Act of 1977) or domestic governmental officials for the purpose of influencing any official act
or decision of such official or inducing him or her to use his or her influence to affect any act or decision of a governmental authority, or (b) any foreign or domestic political party or official thereof or candidate for foreign or domestic
political office for the purpose of influencing any official act or decision of such party, official or candidate or inducing such party, official or candidate to use his, her or its influence to affect any act or decision of a foreign governmental
authority, in the case of both (a) and (b) above in order to assist any Warrantor to obtain or retain business for, or direct business to any Warrantor, as applicable, subject to applicable exceptions and affirmative defenses; (B) used any
funds or will use any proceeds from the sale of the Purchased Shares for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity; or (C) violated any provision of the PRC
Anti-Unfair Competition Law, the PRC Criminal Law or the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder which was or is applicable to any member of the Group Companies or its Subsidiaries
(collectively, the “Anti-Corruption Laws”), and no action, suit, proceeding, investigation or inquiry by or before any Governmental Authority involving any member of the Group Companies with respect to the Anti-Corruption Laws is
pending or, to the best of the Warrantor’s knowledge, threatened. None of Warrantors and their respective directors, administrators, officers, board of directors (supervisory and management) members or employees has made any bribe, rebate,
payoff, influence payment, kickback or other unlawful payment of funds or received or retained any funds in violation of any law, rule or regulation subject to applicable exceptions and affirmative defenses. 

 

	20.	 INSURANCE 

Section 20 of the Disclosure Schedule provides a complete list of each Group Company’s
insurance policies currently in effect. No Group Company has done or omitted to do or suffered anything to be done or not to be done other than any acts in the ordinary course of business which has or would render any policies of insurance taken out
by it or by any other person in relation to any such Group Company’s assets void or voidable or which would result in an increase in the rate of premiums on the said policies and there are no claims outstanding and no circumstances which would
give rise to any claim under any such policies of insurance. 
  

	21.	 CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENTS 

Each current and former employee, consultant and officer of any Group Company has executed an agreement with such Group Company
regarding confidentiality and proprietary information substantially in the form or forms delivered to the counsel for each Purchaser (the “Confidential Information Agreements”). No current or former Key Employee has excluded works
or inventions from his or her assignment of inventions pursuant to such Key Employee’s Confidential Information Agreement. No Group Company is aware that any of the Key Employees is in violation thereof. 

  
 SCHEDULE 5 

	22.	 GOVERNMENTAL AND OTHER PERMITS 

22.1 Each Group Company has all franchises, governmental permits, licenses and any similar authority necessary for the conduct of its
business. No Group Company is in default in any material respect under any of such franchises, governmental permits, licenses or other similar authority. 

22.2 Each of the DomCo and the WFOE has applied and obtained all requisite licenses, clearance and permits required under PRC Laws as
necessary for the conduct of its businesses, and each of the DomCo and the WFOE has complied in all material respects with all PRC Laws in connection with foreign exchange, including without limitation, carrying out all relevant filings,
registrations and applications for relevant permits with the PRC State Administration of Foreign Exchange and any other relevant authorities, and all such permits are validly subsisting. The Founders and other PRC shareholders of the Company (as
applicable) have complied with all reporting and/or registration requirements (including filings of amendments to existing registrations) under the SAFE Rules and Regulations, including without limitation, Circular 37. 

22.3 The registered capital of each of the DomCo and the WFOE has been fully paid up in accordance with the schedule of payment
stipulated in its articles of association and in compliance with PRC Laws, and there is no outstanding capital contribution commitment. 

22.4 The respective articles of association, approval document, certificate of approval and legal person business license of each of the
DomCo and the WFOE (hereinafter referred to as the “Establishment Documents”) have been duly approved and filed in accordance with the Laws of the PRC and are valid and enforceable. 

22.5 The business scope specified in the Establishment Documents of each of the DomCo and the WFOE complies with the requirements of all
relevant PRC Laws. The operation and conduct of the business by and the term of operation of each of the DomCo and the WFOE in accordance with the Establishment Documents is in compliance with the Laws of the PRC. 

22.6 Section 22.6 of the Disclosure Schedule sets out full and accurate details of all loan agreements entered into
by any Group Company regarding any inter-company loan, shareholders loan, foreign exchange loan or any other kind of loan obtained by it. Such loan agreements have been duly registered in accordance with the Laws of the PRC (where necessary) and all
such registrations are validly subsisting under the Laws of the PRC. All proceeds from such loan agreements in an amount equal to the principal amount borrowed under such loan agreements was received by the applicable Group Companies used for such
Group Companies’ operations and for working capital purposes. 
  

	23.	 CORPORATE DOCUMENTS 

The memorandum and articles of association, and all other constitutional documents (or analogous constitutional documents) of
each Group Company are in the form provided to each Purchaser. The copy of the minute books of the Company provided to each Purchaser contains minutes of all meetings of directors and shareholders and all actions by written consent without a meeting
by the directors and shareholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and shareholders with respect to all transactions referred to in such
minutes. 
  

	24.	 LIABILITIES 

No Group Company has any liabilities of any nature, whether accrued, absolute, contingent or otherwise, and whether due or to
become due, except for (i) liabilities set forth in the Delivered Financial Statements of the Company, (ii) trade or business liabilities incurred in the ordinary course of business, and (iii) other liabilities that do not
exceed US$100,000 in the aggregate. 

  
 SCHEDULE 5 

	25.	 COMPLIANCE WITH LAWS 

25.1 Each Group Company is in material compliance with all applicable Laws applicable to it or to the conduct or operation of its
business or the ownership or use of any of its assets or properties. 
 25.2 No event has occurred and no circumstance exists that to
the Warrantors’ knowledge (i) may constitute or result in a violation by any Group Company, or a failure on the part of any Group Company to comply with any Law, or (ii) may give rise to any obligation on the part of any Group Company
to undertake, or to bear all or any portion of the cost of, any remedial action of any nature, except for such violations or failures by a Group Company that, individually or in the aggregate, would not result in any Material Adverse Effect. 

25.3 No Group Company has received any written notice from any Governmental Authority regarding (i) any actual, alleged or likely
material violation of, or material failure to comply with, any Law, or (ii) any actual, alleged or likely material obligation on the part of any Group Company to undertake, or to bear all or any portion of the cost of, any remedial action of
any nature. 
 25.4 No Group Company, nor any director, agent, employee or any other person acting for or on behalf of any Group
Company, has directly or indirectly (i) made any contribution, gift, bribe, payoff, influence payment, kickback, or any other fraudulent payment in any form, whether in money, property, or services to any public official or otherwise
(A) to obtain favorable treatment in securing business for a Group Company, (B) to pay for favorable treatment for business secured, or (C) to obtain special concessions or for special concessions already obtained, for or in respect
of any Group Company, in each case which would have been in violation of any applicable Law or (ii) established or maintained any fund or assets in which any Group Company shall have proprietary rights that have not been recorded in the books
and records of a Group Company. To the Warrantor’s knowledge after due inquiry, the operations of each member of the Group Companies are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting
and other requirements of the anti-money laundering Laws of all relevant jurisdictions where the Group Companies have business activities (collectively, the “Anti-Money Laundering Laws”), and no action, suit, proceeding,
investigation or inquiry by or before any Governmental Authority involving any member of the Group Companies with respect to the Anti-Money Laundering Laws is pending or threatened. 

25.5 The restructuring transactions in connection with the termination of the previous “VIE” structure of the Group Companies
and the Control Documents, including without limitation any Equity Transfers, are in compliance with all applicable PRC Laws, including without limitation Rules on Acquisition of Domestic Enterprises by Foreign Investors (Circular of MOFCOM [2009]
No. 6) (

). 
  

	26.	 ENVIRONMENTAL AND SAFETY LAWS 

To the Warrantors’ knowledge, no Group Company is in violation of any applicable statute, law, or regulation relating to
the environment or occupational health and safety, except where such failure would not have a Material Adverse Effect on such Group Company’s business or properties, and no material expenditures are or will be required in order to comply with
any such existing statute, law or regulation. 
  

	27.	 MINUTES BOOK 

The minutes books of each Group Company, which have been made available to the Purchasers, contain a complete summary of all
meetings and actions taken by directors and shareholders or owners of such Group Company since its time of formation, and reflect all transactions referred to in such minutes accurately in all material respects. 

  
 SCHEDULE 5 

	28.	 MANUFACTURE, MARKETING AND DEVELOPMENT RIGHTS 

Except as disclosed in the Disclosure Schedule, no Group Company has granted rights to manufacture, produce, assemble, license,
market, or sell its respective products or services to any other person and is not bound by any agreement that affects any Group Company’s exclusive rights to develop, manufacture, assemble, distribute, market or sell its respective products or
services. 
  

	29.	 DISCLOSURE; PROJECTIONS 

The Warrantors have made available to each Purchaser all the information reasonably available to the Warrantors that such
Purchaser has requested for deciding whether to acquire the Purchased Shares, including certain of financial projections with respect to the Company (the “Projections”), each of which were prepared in good faith. To the
Warrantors’ knowledge, no representation or warranty of any Warrantor contained in this Agreement, as qualified by the Disclosure Schedule (only to the extent fairly and specifically disclosed therein), no information or document
provided or disclosed by the Warrantors to such Purchaser or its counsel in connection with the negotiation or execution of the Transaction Documents and certificate furnished or to be furnished to such Purchaser at the Closing contain any untrue
statement of a material fact or omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. 

 

	30.	 BUSINESS PLAN AND BUDGET 

The Company has delivered to each Purchaser on or before the Closing a business plan and budget for the twelve (12) months
following the Closing (the “Business Plan”). Such Business Plan was prepared in good faith based upon assumptions and projections which the Founders believe are reasonable and not materially misleading. 

 

	31.	 ENTIRE BUSINESS 

There are no material facilities, services, assets or properties shared with any entity other than the Group Company which are
used in connection with the business of each Group Company. 
  

	32.	 NO LIQUIDATION OR REDEMPTION EVENT 

There have not been any facts, events or circumstance that, individually or in the aggregate, will, or are reasonably expected
to, (i) constitute a Liquidation Event (as defined in the current or past memorandum and articles of association of the Company), liquidation or similar event, or (ii) entitle any holder of Shares to require the Company to redeem any
Shares, in each case pursuant to the current or past memorandum and articles of association of the Company. 

  
 SCHEDULE 5 

 SCHEDULE 6 

DISCLOSURE SCHEDULE 

  
 SCHEDULE 6 

 SCHEDULE 7 

REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS 
  

	1.	 AUTHORIZATION 

Such Purchaser has full power, authority and legal capacity to enter into, deliver and perform the Transaction Documents. The
Transaction Documents to which such Purchaser is a party, when executed and delivered by such Purchaser, will constitute valid and legally binding obligations of such Purchaser, enforceable in accordance with their terms, except (i) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors’ rights generally, and as limited by laws relating to the availability of a
specific performance, injunctive relief, or other equitable remedies, or (ii) to the extent the indemnification provisions contained in the Shareholders’ Agreement may be limited by applicable securities laws. 

 

	2.	 DISCLOSURE OF INFORMATION 

Such Purchaser has had an opportunity to discuss the Group Companies’ business, management, financial affairs and the
terms and conditions of the offering of the Purchased Shares with the Group Companies’ management and has had an opportunity to review the Group Companies’ facilities. The foregoing, however, does not limit or modify the representations
and warranties of the Warrantors in Section 5 of this Agreement, or the right of such Purchaser to rely thereon save as set forth in the Disclosure Schedule. 

 

	3.	 PURCHASE ENTIRELY FOR OWN ACCOUNT 

This Agreement is made with such Purchaser in reliance upon such Purchaser’s representation to the Company, which by such
Purchaser’s execution of this Agreement, such Purchaser hereby confirms, that the Purchased Shares to be acquired by such Purchaser will be acquired for investment for such Purchaser’s own account, not as a nominee or agent, and not with a
view to the resale or distribution of any part thereof, and that such Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, such Purchaser further represents
that such Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Purchased Shares. 

 

	4.	 RESTRICTED SECURITIES 

Such Purchaser understands that the Purchased Shares have not been registered under the Securities Act, by reason of a specific
exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of such Purchaser’s representations as expressed herein. Such Purchaser
understands that the Purchased Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, such Purchaser must hold the Purchased Shares indefinitely unless
they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. Such Purchaser acknowledges that the Company has no obligation to
register or qualify the Purchased Shares, the Conversion Shares for resale except as set forth in the Shareholders’ Agreement. Such Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be
conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Purchased Shares and on requirements relating to the Company which are outside of such Purchaser’s control, and which the
Company is under no obligation and may not be able to satisfy. Such Purchaser understands that Company’s offering of Series E Preferred Shares and Series E-1 Preferred Shares under this Agreement
is not intended to be part of the public offering, and that such Purchaser will not be able to rely on the protection of Section 11 of the Securities Act. 

  
 SCHEDULE 7 

	 	5.	 NO PUBLIC MARKET 

Such Purchaser understands that no public market now exists for the Purchased Shares, and that the Company has made no
assurances that a public market will ever exist for the Purchased Shares. 
  

	 	6.	 LEGENDS 

6.1 Such Purchaser understands that the Purchased Shares and any securities issued in respect of or exchange for the Purchased Shares,
may bear one or all of the following legends: 
 “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY OR OTHER DOCUMENTATION REQUIRED BY THE COMPANY TO EVIDENCE THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.” 

6.2 Any legend set forth in, or required by, the other Transaction Documents. 

6.3 Any legend required by the securities laws of any state to the extent such laws are applicable to the Purchased Shares represented
by the certificate so legended. 

  
 SCHEDULE 7 

 SCHEDULE 8 

CAPITALIZATION TABLE 

  
 SCHEDULE 8 

 SCHEDULE 9 

NOTICES 

  
 SCHEDULE 9 

 EXHIBIT A 

RESTATED ARTICLES 

  
 EXHIBIT A 

 EXHIBIT B 

SHAREHOLDERS’ AGREEMENT 

  
 EXHIBIT B 

 EXHIBIT C 

COMPLIANCE CERTIFICATE 

  
 EXHIBIT C 

 EXHIBIT D 

FORM OF MANAGEMENT RIGHTS LETTER 

  
 EXHIBIT DEX-10.9

 Exhibit 10.9 

ORDINARY SHARE PURCHASE AGREEMENT 

This Ordinary Share Purchase Agreement (this “Agreement”) is made as of January 8, 2021 by and among Tusimple
(Cayman) Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”); and Classic Elite Limited, an exempted company duly formed and validly existing under the laws of
the Cayman Islands (the “Purchaser”). 
 RECITALS 

A. The Company and each Purchaser is executing and delivering this Agreement in reliance upon the exemption from securities
registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States
Securities and Exchange Commission (the “Commission”) under the Securities Act. 
 B. Each Purchaser wishes to
purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, such number of shares of the ordinary shares (the “Ordinary Shares”) of the Company as specified herein. 

NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser hereby agree as follows: 
 ARTICLE 1 

DEFINITIONS 
 1.1
Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings indicated in this Section 1.1: 

“Affiliate” shall have the meaning set forth in Rule 12b-2 of
the regulations promulgated under the Securities Exchange Act of 1934, as amended. 
 “Agreement” shall have the
meaning ascribed to such term in the Preamble. 
 “Allocated Shares” means with respect to such number of whole
shares of Ordinary Shares equal to the quotient resulting from dividing (i) the Subscription Amount by (ii) the Purchase Price, rounded down to the nearest share. 

“Closing” means the closing of the purchase by the Purchaser and sale by the Company of the Allocated Shares to the
Purchaser pursuant to this Agreement on the Closing Date as provided in Section 2 hereof, which shall be contingent on and concurrent with the closing of the sale and issuance of shares of Ordinary Shares by the Company pursuant to the
Underwriting Agreement. 
 “Closing Date” shall be the First Time of Delivery (as defined in the Underwriting
Agreement).  

  
 1 

 “Company Counsel” means Gunderson Dettmer Stough Villeneuve
Franklin & Hachigian, LLP. 
 “Company Deliverables” has the meaning set forth in Section 2.2(a). 

“Company’s Knowledge” means the actual knowledge of the executive officers (as defined in Rule 405 under the
Securities Act) of the Company, after due inquiry. 
 “IPO” means the proposed underwritten initial public offering
of shares of the Company’s Ordinary Shares pursuant to the Registration Statement, with aggregate gross proceeds (prior to any underwriting discounts and commissions) to the Company of not less than US$600 million. 

“Lien” means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or
other restrictions of any kind. 
 “Material Adverse Effect” means a material adverse effect on (a) the results
of operations, assets, liabilities, business, or financial condition of the Company, taken as a whole, or (b) the ability of the Company to perform its obligations under this Agreement, except that any of the following, either alone or in
combination, shall not be deemed a Material Adverse Effect: (i) effects caused by changes or circumstances affecting general market conditions in the U.S. economy or which are generally applicable to the industry in which the Company operates,
(ii) effects resulting from or relating to the announcement or disclosure of the sale of the Shares or other transactions contemplated by this Agreement, or (iii) effects caused by any event, occurrence or condition resulting from or
relating to the taking of any action in accordance with this Agreement. 
 “Material Contract” means any contract of
the Company that has been filed or was required to have been filed as an exhibit to the Registration Statement pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation S-K. 

“Ordinary Shares” has the meaning set forth in the Recitals, and also includes any securities into which the Ordinary
Shares may hereafter be reclassified or changed. 
 “Person” means an individual, corporation, partnership, limited
liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. 

“Purchase Price” means the per share initial public offering price in the IPO (prior to any underwriting discounts and
commissions). 
 “Purchaser Deliverables” has the meaning set forth in Section 2.2(b). 

“Registration Statement” means the registration statement on Form S-1
initially submitted confidentially to the Commission on December 23, 2020, as amended from time to time, including a prospectus filed pursuant to Rule 424 under the Securities Act and any free writing prospectuses, relating to the underwritten
public offering of shares of the Company’s Ordinary Shares. 

  
 2 

 “Rights Agreement” means that certain Amended and Restated
Shareholders’ Agreement, dated December 4, 2020, by and among the Company and the investors named therein. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Shares” means the total number of Allocated Shares purchased by the Purchasers under this Agreement. 

“Subscription Amount” means US$25,000,000.00. 

“Underwriting Agreement” means that certain Underwriting Agreement expected to be entered into by and among the
Company and the several underwriters of the Company’s Ordinary Shares in connection with the IPO (together, the “Underwriters”), relating to the underwritten public offering of shares of the Company’s Ordinary
Shares as described in the Registration Statement. 
 “Voting Securities” shall mean at any time shares of any class
of capital stock of the Company which are then entitled to vote generally in the election of directors. 
 ARTICLE 2 

PURCHASE AND SALE 
 2.1
Closing. 
 (a) Amount. Subject to the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue
and sell to the Purchaser the Allocated Shares, and the Purchaser shall purchase the Allocated Shares from the Company. 
 (b)
Closing. The Closing of the purchase and sale of the Allocated Shares to the Purchaser shall be contingent on and shall take place concurrently with the closing of the IPO at the offices of Company Counsel, 550 Allerton Street, Redwood City,
California 94063 on the Closing Date or at such other locations or remotely by facsimile transmission or other electronic means as the parties may mutually agree. 

(c) Form of Payment. On the Closing Date, the Purchaser shall wire the Subscription Amount, in United States dollars and in immediately
available funds, by wire transfer to the Company’s account, as set forth in instructions previously provided to the Purchaser. 

2.2 Closing Deliveries.

(a) On the Closing, the Company shall issue the Allocated Shares registered in the name of the Purchaser (the “Company
Deliverables”), which Allocated Shares shall be uncertificated shares held in electronic book entry at the Company’s transfer agent. 

(b) On or prior to the Closing, the Purchaser shall deliver or cause to be delivered to the Company the Subscription Amount, in United
States dollars and in immediately available funds, by wire transfer to the Company’s account as previously provided to the Purchaser (the “Purchaser Deliverables”). 

  
 3 

 ARTICLE 3 

REPRESENTATIONS AND WARRANTIES 

3.1 Representations and Warranties of the Company. The Company hereby represents and warrants as of the date hereof and the Closing
Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date), to the Purchaser that, except as set forth in the schedules delivered herewith or disclosed in the Registration Statement:

 (a) Organization and Qualification. The Company is an entity duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its respective incorporation, with the requisite corporate power and authority to own or lease and use its properties and assets and to carry on its business as currently conducted. The Company is not
in violation of any of the provisions of its Memorandum and Articles of Association. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the
business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have a Material Adverse Effect. 

(b) Authorization; Enforcement; Validity. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement and the consummation by it of the transactions contemplated hereby have been duly authorized by all
necessary corporate action on the part of the Company, and no further corporate action is required by the Company, its Board of Directors or its shareholders in connection therewith. This Agreement has been duly executed by the Company and when
delivered in accordance with the terms hereof will constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application. Except as disclosed in the
Registration Statement, there are no shareholder agreements, voting agreements, or other similar arrangements with respect to the Company’s capital stock to which the Company is a party or, to the Company’s Knowledge, between or among any
of the Company’s shareholders. 
 (c) No Conflicts. The execution, delivery and performance by the Company of this Agreement and
the consummation by the Company of the transactions contemplated hereby do not and will not (i) conflict with or violate any provisions of the Company’s Memorandum and Articles of Association or otherwise result in a violation of the
organizational documents of the Company, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any Material Contract, or (iii) result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject, or by which any property or asset of the Company is bound or affected, except in the case of clause (iii) such as would
not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect. 

  
 4 

 (d) Issuance of the Securities. The Shares have been duly authorized and, when issued
and paid for in accordance with the terms of this Agreement, will be duly and validly issued, fully paid and nonassessable and free and clear of all Liens, other than restrictions imposed by any lock-up or
market stand-off agreements to which the Purchaser is party or applicable securities laws, and shall not be subject to preemptive or similar rights. Assuming the accuracy of the representations and warranties
of the Purchaser in this Agreement, the Shares will be issued in compliance with all applicable federal and state securities laws. 
 (e)
Private Placement. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 3.2 of this Agreement, no registration under the Securities Act is required for the offer and sale of the Allocated Shares
by the Company to the Purchaser under this Agreement. 
 (f) Brokers and Finders. No Person will have, as a result of the transactions
contemplated by this Agreement, any valid right, interest or claim against or upon the Company or the Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the
Company. 
 3.2 Representations and Warranties of the Purchaser. The Purchaser hereby represents and warrants as of the date hereof
and as of the Closing Date to the Company as follows:  
 (a) Organization; Authority. The Purchaser is an entity duly
organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite corporate or partnership power and authority to enter into and to consummate the transactions contemplated by this Agreement
and otherwise to carry out its obligations hereunder. The execution, delivery and performance by the Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate or, if the Purchaser is not a
corporation, such partnership, limited liability company or other applicable like action, on the part of the Purchaser. This Agreement has been duly executed by the Purchaser and when delivered by the Purchaser in accordance with the terms hereof
will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application. 

(b) No Conflicts. The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the Purchaser of
the transactions contemplated hereby will not (i) result in a violation of the organizational documents of the Purchaser, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Purchaser is a party, or (iii) result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws) applicable to the Purchaser, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the
aggregate, reasonably be expected to have a material adverse effect on the ability of the Purchaser to perform its obligations hereunder. 

  
 5 

 (c) Restricted Securities. The Purchaser understands that the Allocated Shares are
being issued in a transaction that was not, and will not be, registered under the Securities Act by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of
the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that the Allocated Shares are “restricted securities” under applicable U.S. federal and state securities laws and
that, pursuant to these laws, the Purchaser must hold the Allocated Shares indefinitely unless they are registered with the Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is
available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Allocated Shares for resale. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be
conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Allocated Shares, and on requirements relating to the Company which are outside of the Purchaser’s control, and which the
Company is under no obligation and may not be able to satisfy. 
 (d) Accredited Investor. The Purchaser is an accredited investor as
defined in Rule 501(a) of Regulation D promulgated under the Securities Act. The Purchaser’s principal executive offices are in the jurisdiction set forth immediately below the Purchaser’s name on the applicable signature page attached
hereto. 
 (e) Experience of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Allocated Shares, and has so evaluated the merits and risks of such investment. The Purchaser
is able to bear the economic risk of an investment in the Allocated Shares and is able to afford a complete loss of such investment. 

(f) Access to Information. The Purchaser acknowledges that it has received all the information it considers necessary or appropriate for
deciding whether to purchase the Allocated Shares and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of
the offering of the Allocated Shares and the merits and risks of investing in the Allocated Shares; (ii) access to information about the Company and its respective financial condition, results of operations, business, properties, management and
prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed
investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted by or on behalf of the Purchaser or its representatives or counsel shall modify, amend or affect the Purchaser’s right to rely on
the truth, accuracy and completeness of the Company’s representations and warranties contained in this Agreement. 

  
 6 

 (g) Brokers and Finders. No Person will have, as a result of the transactions
contemplated by this Agreement, any valid right, interest or claim against or upon the Company or the Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the
Purchaser. 
 (h) Reliance on Exemptions. The Purchaser understands that the Allocated Shares being offered and sold to it in reliance
on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and the Purchaser’s compliance with, the representations,
warranties, agreements, acknowledgements and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire the Allocated Shares. 

(i) Market Stand-Off. The Purchaser acknowledges and agrees that it is bound by the market stand-off agreement set forth in Section 11 of Exhibit B to the Rights Agreement, and such agreement is in full force and effect, and following the consummation of the transactions contemplated by this
Agreement will remain in full force and effect, including with respect to the Allocated Shares, and agrees to be bound thereby with respect to the Allocated Shares. 

(j) Legends. The Purchaser understands that the Allocated Shares may bear one or all of the following legends: 

(i) “THE SHARES REPRESENTED BY THIS CERTIFICATE WERE ISSUED IN A TRANSACTION THAT WAS NOT REGISTERED UNDER THE SECURITIES ACT OF 1933, AND
HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A
FORM REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.” 
 “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT
BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES.”
 
 (ii) Any legend required by the Blue Sky laws of any state to the extent such laws are applicable to the Allocated Shares represented
by the certificate so legended. 

  
 7 

 ARTICLE 4 

CONDITIONS PRECEDENT TO CLOSING 

4.1 Conditions Precedent to the Obligations of the Purchaser to Purchase Shares at the Closing. The obligation of the Purchaser to
acquire the Allocated Shares at the Closing is subject to the fulfillment to the Purchaser’s satisfaction, on or prior to the Closing Date, of each of the following conditions, any of which may be waived by the Purchaser: 

(a) Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct in all
material respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and warranties shall be true and correct in all respects) as of the date of this Agreement and as of the
Closing Date, as though made on and as of the Closing Date, except for such representations and warranties that speak as of a specific date. 

(b) IPO Shares. The Underwriters shall have purchased, concurrent with the purchase of the Allocated Shares by the Purchaser hereunder,
the Firm Shares (as defined in the Underwriting Agreement) at the same purchase price (less any underwriting discounts or commissions) per share payable by the Purchaser hereunder. 

(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by this Agreement. 

(d) Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.2(a). 

4.2 Conditions Precedent to the Obligations of the Company to sell Shares at the Closing. The Company’s obligation to sell and
issue to the Purchaser the Allocated Shares at the Closing is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the Company: 

(a) Representations and Warranties. The representations and warranties of the Purchaser contained herein shall be true and correct in
all material respects as of the date of this Agreement, and as of the Closing Date as though made on and as of the Closing Date, except for representations and warranties that speak as of a specific date. 

(b) IPO Shares. The Underwriters shall have purchased, concurrent with the purchase of the Allocated Shares by the Purchaser hereunder,
the Firm Shares (as defined in the Underwriting Agreement) at the same purchase price (less any underwriting discounts or commissions) per share payable by the Purchaser hereunder. 

(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by this Agreement. 

  
 8 

 (d) Purchaser Deliverables. The Purchaser shall have delivered the Purchaser
Deliverables in accordance with Section 2.2(b), as well as any information required by the Company’s transfer agent in order to establish an electronic book entry for the Purchaser. 

(e) Lock-Up Agreement. The Purchaser shall have executed and delivered to the Underwriters a lock-up agreement in substantially the form delivered to the Underwriters pursuant to the Underwriting Agreement, and such Lock-Up Agreement shall be in full force and effect.

 ARTICLE 5 

MISCELLANEOUS 
 5.1
Termination. This Agreement shall automatically terminate upon the earliest to occur of (i) a written notice from the Company to the Purchaser, provided that such notice shall be delivered prior to the public filing of the Registration
Statement, (ii) the withdrawal by the Company of the Registration Statement, or (iii) following the execution of the Underwriting Agreement, the termination of such Underwriting Agreement in accordance with its terms. 

5.2 Fees and Expenses. Each party shall pay its own fees and expenses incurred in connection with the negotiation, preparation,
execution, delivery and performance of this Agreement. 
 5.3 Entire Agreement. This Agreement, together with any exhibits and
schedules hereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or written, with respect to such matters, which the
parties acknowledge have been merged into such documents, exhibits and schedules. At or after the Closing, and without further consideration, the Company and the Purchaser will execute and deliver to the other such further documents as may be
reasonably requested in order to give practical effect to the intention of the parties under this Agreement. 
 5.4 Notices. All
notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. The address for such notices and communications shall be as
follows: 
  

			
	If to the Company:	  	Tusimple (Cayman) Limited
		  	9191 Towne Centre Drive, Suite 600
		  	San Diego, California 92122
		  	Attention: Cheng Lu, President and CEO
		
	With a copy to:	  	 Gunderson Dettmer Stough Villeneuve Franklin

& Hachigian, LLP

		  	550 Allerton Street
		  	Redwood City, California 94063
		  	Attention: Zhen Liu and Jeff Vetter
		
	If to the Purchaser:	  	Class Elite Limited c/o 38th Floor, Champion
		  	Tower, 3 Garden Road, Central, Hong Kong
		  	Attention: Daniel Wong/ Derek Fong

  
 9 

 or such other address as may be designated in writing hereafter, in the same manner, by such Person. 

5.5 Amendments; Waivers; No Additional Consideration. No amendment or waiver of any provision of this Agreement, nor any consent or
approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. 

5.6 Construction. The headings herein are included for convenience of reference only and are not intended to be part of, or to affect
the meaning or interpretation of, this Agreement. 
 5.7 Successors and Assigns. The provisions of this Agreement shall inure to the
benefit of and be binding upon the parties and their successors (including without limitation any continued entity by way of reorganization, redomestication or continuation) and permitted assigns. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 

5.8 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California, without
regard to the principles of conflicts of law thereof. 
 5.9 Survival. The representations and warranties contained herein shall
survive the Closing and the delivery of the Shares for a period of one (1) year from the Closing Date. The agreements and covenants contained herein shall survive for the applicable statute of limitations. 

5.10 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and
the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. 

5.11 Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and
upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 5.12 Remedies. In addition to being entitled to
exercise all rights provided herein or granted by law, including recovery of damages, each Purchaser and the Company will be entitled to specific performance under this Agreement. The parties agree that monetary damages may not be adequate
compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a
temporary restraining order) the defense that a remedy at law would be adequate. 
 [SIGNATURE PAGES FOLLOW] 

  
 10 

 IN WITNESS WHEREOF, the parties hereto have caused this Ordinary Share Purchase
Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. 
  

			
	 COMPANY:

	
	 TUSIMPLE (CAYMAN) LIMITED

		
	By:	 	 /s/ Cheng Lu

	Name:	 	Cheng Lu
	Title:	 	President

 IN WITNESS WHEREOF, the parties hereto have caused this Ordinary Share Purchase
Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. 
  

			
	 PURCHASER:

	
	 CLASSIC ELITE LIMITED

		
	By:	 	 /s/ Peter A. Allen

	Name:	 	Peter A. Allen
	Title:	 	Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]